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ABSTRACT 
This study examined the effects of exercise and diet-induced weight loss on markers of 
inflammation in obese females. Forty-nine obese women (age 48.2±10.5 years, height 
63.5±2.7cm; weight 203.3±30.5 kg; BMI 35.6±5.6 kg/m
2
; 45.9±4.4 % body fat) 
completed a 12-week study (exercise group (EX): n=29; control group (C): n=20). 
Participants followed an energy-restricted diet (1,200 kcal/d for 1-week and 1,500 kcal/d 
for 11 weeks; 30% CHO, 45% P, and 25% F) while participating in a 30-min circuit 
resistance-training (3 days/wk) and 30 min walking program on non-workout days. 
DEXA body composition, fitness, and serum/white blood cells samples were obtained at 
0, 4, 8 and 12 wks. The expression of microRNA (21 and 146a) and the expression 
levels of IL-6, TNF-α, (PTEN, TRAF6)/PI3k/AKT/NF-kB were measured by real-time 
RT-PCR at 0 and 12 wks.  Data were analyzed by MANOVA and presented as changes 
from baseline after 12 wks for the EX and C groups. Overall MANOVA analysis 
revealed a significant time effect (p=0.004) and group x time effect (p=0.004) for body 
composition measures. Participants in the EX group experienced significant changes in 
body weight (EX -4.0±4.4 kg; C 0.1±3.0 kg, p=0.001), fat mass (EX -3.8±4.0 kg; C -
0.03±2.0 kg, p<0.001), and percent body fat (EX -2.7±3.4%; C -0.1±1.7%, p=0.002).  
Overall MANOVA analysis revealed a significant time effect (p<0.001) and group x 
time effect (p=0.003) for measures of fitness. Overall significant MANOVA interaction 
was observed among EX and C groups (Wilks’ Lambda p<0.001) on markers of 
inflammation. Significant interactions were observed among groups in microRNA 21 
(EX -1.5±2.34; C 0.13±2.2, p=0.03), mRNA expression levels of PTEN (EX -4.5±3.2; C 
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-1.6±3.4, p=0.005), IL-6 (EX -2.8±3.6; C 2.8±2.2, p=0.00); and, TNF-α (EX -0.52±2.5; 
C 2.3±1.9, p=0.00). Changes in microRNA (21 and 146a) were positively and 
significantly correlated to body weight, total weight, fat mass, and body fat percent, with 
circulatory levels of IL-6 and TNF-α. Results indicate that 12-wks of participation in an 
exercise and weight loss program significantly affects microRNA 21 and its target gene 
PTEN, mRNA TNF-α, and mRNA IL-6 levels suggesting an anti-inflammatory response 
compared to a control group.  
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CHAPTER I 
INTRODUCTION 
Overweight/obesity is the most common chronic disease situation in the world. 
Overweight is a problem that complicates and exacerbates the growth process in human 
life all over the world (67). The rising incidence of overweight in the United States and 
the world population has brought about intense concern in the exercise, nutrition and 
medical community (108, 169). Approximately 68.5% of the United States adult 
population is considered either overweight or obese, and this percentage has increased 
over the last few decades (46, 48). Multiple factors including various genetic, 
environmental and physiological changes within the human body can lead to overweight 
and its consequences (108, 169). The adverse effects physical of inactivity and poor 
dieting include; overweight, obesity, diabetes, metabolic syndrome and even death 
(169). The complication of obesity includes medical problems such as: metabolic 
abnormalities, diabetes, cardiovascular diseases, arthritis, pulmonary abnormalities, 
urinary incontinence, cataracts and certain types of cancer (85). Other major concerns in 
the obese population are physical inability, poor lifestyle, overeating, increased body 
composition and high risk of stress (179). Many research studies have shown that 
exercise and diet are highly effective in promoting weight loss and improving markers of 
health and enhancing fitness (71, 72, 81, 169). However, the major mechanisms 
underlying the pathogenesis of overweight remain obscure and need more research (100, 
144, 169). 
 2 
 
 
Exercise and diet plays a critical role in weight loss, metabolism, physiological 
function and weight maintenance in obesity (29). Physical inactivity and excess body 
weight in the obese population may increase or exacerbate treatment related decrements 
in the quality of life due to increasing body weight. Prior research findings in our lab 
showed that overweight women participating in a 14-week resistance-based circuit 
training and diet program lost 10-14 pounds, a 10-14% increase in muscular 
strength/endurance, and a 17% and 15% decrease in fasting leptin and insulin, 
respectively, while insulin sensitivity improved by 19% (71, 72, 80-82). Exercise and 
diet-induced weight loss have the ability to improve overall body health by reducing 
total body weight and can have a positive effect on body composition (71, 72, 74, 81). 
Exercise and diet-induced weight loss may influence gene expression (27, 28). Also the 
expression of some cytokines and proteins (116, 118, 121), as well as alterations of 
mRNAs and microRNAs gene transcription (87, 88).  
Cytokines mediate communication between cells in the human body and are used 
extensively in cellular communication between the endocrine, immune, nervous and 
circulatory system in the development, growth and gene regulation (117, 122). 
Cytokines are produced from muscles and adipose tissues (113, 120-123). Cytokines 
regulate local defense reactions in tissues, organs and systems.  The expression of 
cytokine genes in research may help to determine functional qualities of metabolism in 
physiological systems. Research has shown that contracting muscles release IL-6 into 
circulation during exercise (116, 120). The plasma levels of IL-6 increased from about 
20 to 100 fold in response to intense exercise (119, 121).  The IL-6 released during 
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exercise from contracting muscles may affect many other tissues and organs of the 
human body (123, 124). For example, Keller and colleagues (68, 69) isolated nuclei 
from muscles biopsies obtained before and during exercise and demonstrated that 
transcription for Il-6 increases rapidly after the onset of exercise and decreases post 
exercise. Weight reduction through exercise training decreases serum concentration of 
these inflammatory makers (IL-6 and TNF-α) (160). Tsukui and associates (160) 
conducted a 5 month exercise training program, 30-45 min/day for 4-5 days /week at 40-
50% VO2max and concluded that weight loss significantly decreased serum concentration 
of TNF-α  These findings were negatively correlated with HDL cholesterol levels, and 
reductions in BMI and percent body fat (160). For example, Buford and colleagues (18) 
evaluated the effects of eccentric exercise on inflammatory gene expression on 29 males 
for 45 min downhill treadmill running at a 10
o
 for 45 min at 60% of the VO2max. The 
researchers reported a significant up-regulation (p < 0.05) in IL6 expression compared 
with baseline and significant increases in IL-6 mRNA at 3 h (p < 0.001) and 24 h 
(p=0.043) post exercise, and no significant changes were observed for TNF-α and NF-
kB (p105/p50) expression (18). 
The first microRNA was discovered in 1993 (35, 75). MicroRNAs (microRNAs) 
are small (21–25 nucleotides in length), non-coding RNAs (54, 58, 75), that play an 
important regulatory role targeting mRNA transcripts for translational repression. 
MicroRNAs play a very important role in a variety of biological processes, including 
development, differentiation, apoptosis, lipid metabolism and cancer (75).  They are 
present in all body fluids and are active moieties that can influence gene expression and 
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physiology activity (54, 58). MicroRNA are regulated and transcribed like protein 
coding genes and are emerging as highly specific serum biomarkers with a potential 
clinical applicability (54, 58). They have been reported to modulate adipocyte 
differentiation as well as insulin secretion (75). Research done on microRNAs showed 
that the overexpression of specific microRNAs in human cells may regulate many 
transcripts predicted to bind the microRNA molecule (86, 143).  For example, Esau et al 
(39) found that reducing microR-143 by transfecting antisense oligonucleotides inhibited 
adipocyte differentiation in vitro, suggesting that microRNAs may play a role in the 
regulation of key adipose tissue processes and could therefore represent novel targets for 
the treatment of overweight and obesity. MicroRNAs have also been shown to regulate 
metabolic and physiological processes associated with type 2 diabetes including insulin 
signaling and glucose homeostasis (54, 58, 75, 90). MicroRNA play a very important 
role in the regulation of glucose and lipid metabolism through adipocyte proliferation 
and differentiation as well as in cholesterol biosynthesis (58). The emergence of 
microRNA (92) in research provides an opportunity to understand the molecular factors 
that control metabolism and physiological regeneration and function.  There is evidence 
that exercise and nutrition may impact microRNA gene regulation (54, 58, 90, 92).  
However, more research is needed to understand the impact of exercise training and 
weight loss on microRNAs.   
The nuclear factor kappa beta (NF-kB) signaling pathway is another important 
molecular pathway affected by exercise that is not well-understood.  NF-kB is found in 
almost all animal cell types and is involved in cellular responses to stimuli such as stress 
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and inflammation (151, 153). The nuclear factor-Kb (NF-kB) p50/p65 is a heterodimer 
of the rel (NF-kB1, NF-kB2, relA, relB and c-Rel) family that regulates a variety of 
cellular functions (151, 153, 165). NF-κB controls many genes involved in inflammation 
e,g. (TNF-α, IL-6) (165) The NF-kB activity includes a large variety of factors linked to 
inflammatory cytokines and may be very important in understanding the effects of 
exercise on different genes (165). Protein modulators such as phosphatase and tensin 
homologue deleted from Chromosome-10 (PTEN), TNF-receptor-associated factor6 
(TRAF6), phosphatidylinositol-3-kinase (PI3k), protein kinase B (AKT or PKB), nuclear 
factor kappa beta (NF-kB) can induce changes that are beneficial to whole organism 
depending on whether they are modulated in an up-stream or downstream manner. 
Exercise and diet-induced weight loss could be one of those essential ways of regulating 
cellular gene functions (87, 88, 90, 165). Physical exercise can induce the activation of 
NF-kB in blood lymphocytes (165).  For example, Vider and colleagues (165) conducted 
a study on 12 healthy male endurance and mixed aerobic athletes on a treadmill for 
60min at 80% VO2 max after a 5 min warm-up. They reported that physical exercise 
caused activation of NF-kB in 8 of 12 subjects by significantly increasing NF-kB 
activity by greater than 50% (p=0.002) and also increased plasma TNF-α (p = 0.003 
(165). 
Consequently, additional research is needed to understand the effects of exercise 
and diet-induced weight loss on microRNAs expression through target genes (PTEN, 
TRAF6, PI3K, AKT and NF-kB) (8, 9, 87, 90, 168). Moreover, how exercise and diet-
induced changes in microRNA expression may affect secondary responses such as 
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protein synthesis, cell growth and inflammation (IL-6 and TNF-α) (126, 129, 130, 133)   
Thus, the main foci of this study was to examine whether obesity is associated with 
increases in inflammation; whether exercise and diet-induced weight loss reduces 
inflammation; and, whether changes in expression levels may explain how exercise and 
diet-induced weight loss can be beneficial in improving markers of health, fitness and 
inflammation.  
Statement of the Problem 
Does exercise and diet-induced weight loss affect the inflammatory responses 
associated with obesity?  
Purpose of the Study 
The purpose of the study was to examine how exercise and diet-induced weight 
loss influences markers of inflammation and regulate genes associated with obesity.  
General Study Design 
This study was conducted as a randomized, repeated measure, prospective 
clinical trial in an obese female population ages 18-65 years. Participants meeting 
entrance criteria were randomly assigned to a 12-week exercise and diet-induced weight 
loss group designed to improve fitness and promote fat loss, regulate genes related to 
inflammation and reduce inflammatory markers or a non-diet, non-exercise control 
group. The independent variable was exercise and diet intervention. The dependent 
variables were: body composition (weight, fat mass, fat free mass, percent body fat); 
markers of fitness; inflammatory cytokines IL-6 and TNF-α; and microRNAs (21 and 
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146a) and their target genes and the NF-kB signaling pathway (PTEN, 
TRAF6)/AKT/PI3K/NF-kB.   
Hypotheses 
The following hypotheses have been based on the existing literature: 
H1-The exercise and diet intervention will promote significant differences in body 
composition compared to controls.   
H2-The exercise and diet intervention will promote significant differences in markers of 
health and fitness compared to controls.   
H3-The exercise and diet intervention will promote significant differences in mRNA IL-
6 expression compared to the controls  
H4-The exercise and diet intervention will promote significant differences in mRNA 
TNF-a expression compared to the control  
Null Hypotheses  
Based on Previous research, the following relationships have not demonstrated. 
Therefore the following null hypotheses were stated. 
Ho1-The exercise and diet intervention will not result in significant differences in mRNA 
TNF-a expression compared to the controls.  
Ho2-There will be no significant differences between groups in changes in microRNAs 
(21, 146a) expression.  
Ho3-There will be no significant differences between groups in changes in mRNA PTEN 
expression.   
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Ho4-There will be no significant differences between groups in changes in mRNA 
TRAF6 expression.  
Ho5-There will be no significant differences between groups in changes in mRNA PI3k 
expression.  
Ho6-There will be no significant differences between groups in changes in mRNA AKT 
expression.  
Ho7-There will be no significant differences between groups in changes in mRNA NF-
kB expression.   
Delimitations 
The research study followed the guidelines listed below: 
1. There were approximately 50 sedentary overweight female participants (BMI > 27) 
ages 18-65 that participated in the study. 
2. Participants were recruited with flyers posted on campus, physician offices/clinics, 
and retirement facilities. Advertisements were run in the local newspapers and 
Radio. 
3. Familiarizations and testing sessions were conducted in the Exercise and Sport 
Nutrition Laboratory (ESNL) at Texas A&M University. 
4. Participants were randomly assigned to one of two treatment groups, (exercise and 
diet-induced weight loss group and a control group).   
5. Participants followed the exercise prescription guidelines in a supervised exercise 
program three times per week throughout the investigation. 
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Limitations 
1. Participants were sedentary and obese females (BMI > 27) between the ages of 18-65 
years, met medical clearance and qualifying criteria. 
2. Participants in the exercise and diet-induced weight loss group were required to 
adhere to an exercise program three times per week throughout the investigation.  
Assumptions 
1. Participants followed the exercise and diet-induced weight loss program as specified 
by the assigned high protein diet regimen only. 
2. Participants adhered to verbal and written instructions, on more than one occasion to 
refrain from exercise for 48 hours prior to baseline testing. 
3. Participants fasted for 12 hours prior to lab collection. 
4. Participants followed the intensity guidelines for all work outs per instructions.  
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CHAPTER II 
LITERATURE REVIEW 
Background 
There is evidence that exercise can both cause and attenuate inflammation. 
Acute, unaccustomed exercise can cause muscle and connective tissue damage, 
especially if done at high intensities and for prolonged durations. This typically 
manifests as delayed onset muscle soreness which is preceded by microstructural 
skeletal muscle damage (e.g. streaming z disks), inflammatory cell infiltration, and 
elevation of muscle-specific creatine kinase isoforms (50, 51). In some cases, 
inflammatory cytokines (IL-6 and TNF-α) and target genes can be detected in peripheral 
blood of people after high intensity, unaccustomed exercise, especially if lengthening 
contractions are performed (45). This damaging response is attenuated if exercise is done 
repeatedly as the tissue adapts to the new overload stress. Indeed, blocking the 
inflammatory response using broad spectrum anti-inflammatory drugs that can reduce 
muscle adaptation and, ultimately, increase muscle performance induced by exercise 
may be beneficial (102).  
On the other hand, some studies have demonstrated that regularly performed 
cardiovascular exercise training may reduce markers of systemic inflammation (172, 
174, 175). It is this literature that will be the focus of this review because of the strong 
association between elevated systemic inflammatory markers and chronic diseases of the 
aged and obese (172). Evidence regarding non-pharmaceutical means to reduce chronic 
inflammation would be important due to the potentially harmful side effects of 
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medications. Weight loss induces marked alterations in whole body metabolism and 
physiological function and this may result in cellular alteration that can be very 
beneficial during an exercise and diet-induced weight loss program and reducing 
diseases situation such as cardiovascular diseases, insulin resistance, diabetes, 
overweight and obesity.  
Prevalence of Obesity in Women 
Approximately 68.5% of the United States adult population is considered either 
overweight or obese (47), and this percentage has increased over the last few decades. 
The prevalence of overweight in the United States has been steadily on the rise for 
several decades; growing from 44.8% of our population in the early 1960s to 68.5% in 
2010 (46, 48, 67, 127). Women have experienced a particularly sharp increase in the 
prevalence of obesity going from 40.2% to 63.9% over that same time frame (127). The 
World Health Organization (WHO) estimates that globally 1.6 billion adults are 
overweight and at least 400 million adults are obese (1). The frequency of high BMI also 
varies between racial groups and somewhat between different income brackets; white 
females have the lowest percentage (60.2%) whereas Black or African American women 
have a much higher occurrence (80.3%). All socioeconomic levels showed reasonably 
high frequencies of overweight/obesity. BMI readings however the highest percentage 
occurs with persons living above the poverty level, but not making more than 200% of 
the poverty level income (70.9%) and the lowest percentage was observed in persons 
making more than 400% the poverty level income (66.7%) (67).  
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Multiple factors including various genetic, environmental and physiological 
changes within the human body can lead to becoming obese.  Obesity has been generally 
believed to be a direct result of the imbalance between energy intake and energy 
expenditure although we now know obesity is much more complicated than these 
factors. Obesity increases excess fat storage in adipose tissue, liver and muscle and can 
result in physical inactivity and increase mortality. The complications of obesity can 
include medical problems such as: metabolic abnormalities, arthritis, pulmonary 
abnormalities, urinary incontinence, cataracts and certain types of cancer (85). The 
accumulation of adipose tissue associated with obesity is clinically associated with 
diseases such diabetes, hypertension, insulin resistance and cardiovascular diseases (43). 
Obesity has been associated with inflammation and obesity-induced inflammation has 
been reported to adversely affect the function of organs and tissues of the human body 
such as the pancreas, liver, skeletal muscle, heart, and joints. Obesity has also been 
reported to increase the activity of NF-kB in the liver, skeletal muscle and the 
transcription of its target genes primarily responsible for the activation of NF-kB and  
reduction of obesity-induced inflammatory cytokines (IL-6, TNF-a) (19, 107, 169, 175). 
Most obese individuals have large muscle mass.  However, traditional weight 
loss programs (diet only or diet and aerobic exercise) typically promote loss in muscle 
mass leading to a reduction in resting energy expenditure (REE) which is associated with 
weight regain. A decrease in muscle mass in obesity not only impacts metabolic 
disorders (i.e., insulin resistance) but significantly affects physiological and metabolic 
function. Adherence to a higher protein diet and/or incorporation of resistance-exercise 
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into a training program can increase energy expenditure, maintain or increase muscle 
mass during weight loss, and minimize reductions in REE (71, 72, 79). The above 
beneficial effects on the human body can help to maintain body weight and improve 
metabolic functions, regulate gene expression, reduce obesity-induced inflammation and 
improve on markers of health and fitness. However, the major mechanisms underlying 
the pathogenesis of obesity remain obscure and more research is needed to understand 
obesity related induced inflammation and its consequences in humans. 
Defining Inflammation and Markers  
 Inflammation can be defined as the body’s natural means of stimulating healing 
or repair (59). Inflammation is a reaction of microcirculation that is characterized by the 
migration of serum proteins and leukocytes from blood to extravascular tissues (32). 
This migration is regulated by the release of cytokines such as interleukins (IL-6, IL-1, 
IL-10, IL-8), tumor necrosis factor-alpha (TNF-α), and monocyte chemo-attractant 
protein-1 (MCP-1). The release of these metabolites is sometimes accompanied by 
increases in temperature, pain, redness and loss of tissue function (59). The human body 
uses acute inflammation as a means to repair, heal and regenerate itself following events 
such as pain, redness, swelling and heat and tissue damage. Chronic inflammation and 
oxidative stress may be caused by environmental factors, lifestyle and diet depending on 
where the individual lives.  
Relationship of Obesity to Inflammation 
Obesity is associated with inflammation and serum concentrations of various 
cytokines are increased in obese individuals (34). Obesity is also associated with 
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alteration of the immune system and function, the effect of obesity on the immune 
system may vary (34). Obesity can be defined as an overabundance of free fatty acids 
secreted from a large reservoir of adipose tissue and can also be characterized as a state 
of chronic low-grade inflammation (34, 60, 109, 110). The metabolism and 
physiological effects of obesity can affect the entire body system. The deposition of 
abdominal fat can alter metabolic pathways and lead to excess energy (fat) redirected 
towards peripheral organs (115). Obesity is a disease that predisposes humans to 
increasing risk of many other diseases including, diabetes, fatty liver, cancer and 
immune disorders (164). Obesity has been characterized as a state of low grade or 
chronic systemic inflammation due to the abnormal circulating levels of inflammatory 
markers released from increased size of adipocytes caused by excess lipid storage in the 
obese (41, 174, 176, 179). Obesity is associated to chronic inflammation characterized 
by increased production of pro-inflammatory cytokine (IL-6 and TNF-α) and C-reactive 
protein (CRP) (156, 158, 159). IL-6 and TNF-α level from adipose tissue and in 
circulation are highly elevated in obese and correlates to fasting glucose, insulin, 
triglycerides, free fatty acids levels (62, 87-90). These markers of inflammation have 
been associated with increases in the risk of many diseases associated with obesity such, 
heart disease, diabetes, and mortality among older adults (37, 45, 83, 88, 89). IL-6 and 
TNF-a expression levels are very high in obese adipose tissues about 10-fold than in 
adipose tissues in lean individuals (38, 65-69).  
The expression of IL-6 is higher in visceral than in peripheral adipocytes and the 
plasma concentrations of IL-6 increases with obesity as much as 30% of total body IL-6 
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production humans (56, 76, 125, 136, 180). This tremendous increase in IL-6 increases 
lipolysis and fat oxidation in humans (56, 76, 125, 136, 180). A few studies have also 
shown that IL-6 and TNF-α (159, 160) are expressed in adipose tissue with in vitro 
studies proving great evidence of their release from visceral fat cells than subcutaneous 
fat cells (159, 160). For example, Yudkin et al (179) reported that about 20% of IL-6 
levels could be used to explain anthropometric measures of obesity and its distribution. 
They and another group concluded that it was unclear whether adipose tissue is the 
major source of IL-6 production (179, 180). Trujillo et al (159) conducted a study to test 
the effects IL-6 on leptin and lipolysis at 5 h, 24 h and 48 h by obtaining adipose tissue 
samples from some obese subjects with BMI > 57 kg/m
2
 and reported that IL-6 increase 
lipolysis by about 79% and leptin by about 90% at 48 h and no significant effects at 5h 
and 24 h.  In obesity blood cell expression levels of pro-inflammatory cytokines such as 
Il-6 and TNF-α are elevated and may contribute to the increased levels of inflammation 
and previous studies have shown that these cytokines can be reduces via exercise and 
diet (174). You et al (175) conducted a 6 month study to show that exercise 20 min/d 3 
d/wk at 50- 55% heart rate reserve for one week and changing to 45-60 min at 65-70% 
heart rate reserve for the rest of the time on a 250-350 kcal/d hypocaloric diet had 
significant changes on IL-6 and TNF-a overtime with p<0.05 and p<0.001 respectively. 
To understanding the link between obesity and inflammation and why obesity is 
a state of low grade to chronic inflammation, is important to conduct studies that are 
aimed at identifying those molecular mechanisms that are involved in regulation in the 
obese (156). In obesity treatments such as dieting, exercising and losing weight can 
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trigger released of these molecules into circulation to various target organs and can 
cross-regulate each other to reduce higher levels of pro-inflammatory cytokines (156). 
The inflammatory cytokine, IL-6 levels from adipose tissue in circulation are highly 
elevated in obese and correlates to fasting triglycerides, free fatty acids levels (159). IL-6 
expression is very high in obese adipose tissues to about 10-fold that in adipose tissues 
in lean individuals (56, 76, 125, 136, 180). Other studies confirm that elevated levels of 
IL-6 and TNF-α are a strong predictor for the development of myocardial infarction and 
type 2 diabetes and has also been shown to be directly linked to overweight, obesity and 
insulin resistance in the liver (85-88, 98). Adipose tissue plays a role in regulating body 
weight and secretes products such as leptin, adiponectin, interluekin-6, TNF-α, 
angiotensinogen, sex steroids, glucocorticoids and many other genes. Many of these 
products have been present in the literature since the mid-1990s but were not always 
connected to overweight or obesity (120, 121). 
Effects of Diet-Induced Weight Loss on Inflammatory Markers 
Prior research has shown that macronutrients and obesity can activate 
inflammation (100, 144). For example, increase in energy intake and energy imbalance 
have both been shown to induce and increase inflammatory markers levels potentially 
through increase in the activities of NF-kB and oxidative stress and other accompanied 
disease situation (100). Shoelson et al (144) demonstrated that intravenous lipid infusion 
of triglycerides plus heparin in normal subjects raised the levels of free fatty acids (FFA) 
compared to those seen in obese subjects, which consequently led to inflammation as 
determined by inflammatory markers response (144). Excess adipose tissue and obesity 
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is associated with increases in inflammatory cytokines Il-6 and TNF-α (60, 73); whereas, 
weight loss decreases the levels of these inflammatory makers (60, 73, 102, 111). For 
example a study (2) conducted by a different group reported that macronutrient intake in 
obese subjects by caloric restriction to about 1000 kcal/day for a period of 4 wks 
including a 48 h fasting period led to a reduced level of oxidative stress and 
inflammatory mediators (2). Ferrante Jr (43) reported that in obese individuals, weight 
loss following bariatric surgery reduces adipose tissue macrophage content and this 
reduction may lead to a reduction in inflammatory gene expression and other associated 
molecules. This was also confirmed by other studies (43, 178).  
Dahlman and associates (31) conducted a study on 40 obese individuals assigned 
to a moderate-fat, moderate carbohydrate or low-fat, high carbohydrate hypoenergetic (-
600 kcal/d) diet for 10 wks. They reported that both diets resulted in about 7.5% of 
baseline weight loss and a total of 52 genes were significantly up-regulated and 44 genes 
were down-regulated (31). Another study of same kind was investigated on 25 obese 
subjects following a 10 wk hypocaloric (low-fat and high-fat diets) programs with either 
20-25 or 40-45% of total energy derived from fat, they again reported that both groups 
lost 7kg and 10 genes showed a significantly different response to the diets (167). They 
all concluded that macronutrients have a secondary role in changes in gene expression 
after energy-restricted diets and weight loss same as a few other studies listed on the 
table below (31, 167). Mello and coworkers (34) also showed that weight reduction for a 
period of 33 wk on the American Heart Association diet with a mean deficit caloric 
intake of about 500 kj/d on obese women significantly reduced TNF-α by 37.6%  and 
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increased  IL-6 by 21.4% but not significant. Table 1 provides a summary of some other 
studies that have been done to look at the effect of weight loss including weight loss 
through surgery on inflammatory makers following calorie and diet restriction on obese 
men, women and children. 
Effects of Acute Exercise Training on Inflammatory Markers  
Exercise is a safe and inexpensive anti-inflammatory medicine that could be used 
by obese individuals to reduce obesity and its consequences (68). Exercise training 
depending on its duration and intensity engages whole body movements and may be the 
best means of attaining the anti-inflammatory effects of exercise. As already mentioned 
above, IL-6 is one of the most important inflammatory cytokines released during 
exercise and others include TNF-α, IL-1, Il-8, IL-10 (23, 69, 116, 118). Exercise and 
training adaptations affect the human body by producing beneficial effects that will 
improve and regulate whole body metabolic and physiological function (119, 120). 
Rising exercise intensity or full body muscle contraction and glycogen depletion during 
exercise are the major exercise elements involved in the release of IL-6 from contracting 
muscle and adipose tissue from about 20 to 100 fold compared to resting levels of IL-6 
(17, 42, 96, 116, 120, 138, 145, 146)  (68). For example following exercise, the basal IL-
6 level may increase up to 100 fold during a marathon race (122). Margeli et al (94) 
reported that in a race that consisted of a continuous, prolonged and brisk exercise; a 246 
km spartathlon race in less than 36 h IL-6 levels increased up to about 8000-fold. Other 
studies conducted by Keller et al and Steensberg et al (146) in response to exercise, they 
showed that an increase in IL-6 mRNA content from contracting muscles could be 
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detected after 30 min of exercise and up to about 100-fold increase of IL-6 mRNA 
content at the end of the exercise bout (146). 
Steensberg et al (145) reported on a study they conducted that a correlation exist 
between the exercise intensity and the high increase in plasma IL-6 and the appearance 
of IL-6 in blood. They showed that when adrenaline was infused in some volunteers 
during 2.5 h of running, plasma IL-6 increased only by 4-fold with rhIL-6 infusion and 
increased to about 30-fold without rhIL-6 infusion during exercise. A few other studies 
have shown that IL-6 level depends on the duration, intensity and type of exercise and at 
the onset of exercise compared to basal levels (116, 118-124). For instance, a study 
(138) conducted on overweight/obese children and adults who performed  a 30 min 
intermittent exercise test consisting of ten, 2 min bouts of constant work on a cycle 
ergometer  with 1 min rest interval at a VO2max of about 80%. They reported that, 
throughout the exercise in the obese group, IL-6 concentration were quantitatively 
greater (range 20.5-24.3 pg/ml) than in the control group (range 10.9-11.7 pg/ml). That 
TNF-α was significantly greater in the obese group (range 3.2-3.6 pg/ml than in the 
control group (range 2.1-2.3 pg/ml) (138).  Table 2 shows some selected studies on the 
effects of physical activity on inflammatory biomarkers.  
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Table 1: Some published data on the effects of weight loss on inflammatory markers 
 Author                                 Participants /BMI (kg/m2)                           Intervention                      Duration           weight loss                                         Effects on inflammation 
Xydakis et al, 2004 (173) 
40 obese adults BMI 
38.9 ± 1.0   
 
 
600--‐800 kcal/day 
Very--‐low--‐calorie diet 
4--‐6 weeks 7.0% of weight CRP ↓14%; no change in TNF--‐α 
Gallistl et al, 2001 (52) 49 obese children  
BMI 26.7 ± 1.4 
 
908--‐1194 kcal/day energy-restricted  
diet 
3 weeks 5.2% of BMI 
3.1% of fat mass 
IL--‐6 ↓49% 
Bastard et al, 2000 (11) 14 obese women 
BMI 39.5 ± 1.1 
941 kcal/day 
Very--‐low--‐calorie diet 
3 weeks 5.3% of BMI 
8.5% of fat mass 
IL--‐6 ↓17% 
no change in CRP, TNF--‐α 
Long-term behavioral changes: 
Marfella et al, 2004 (93) 67 obese  
BMI 36.5 ± 1.8 
1300 kcal/day energy--‐restricted diet, increased 
exercise 
12 months 13.4% of weight CRP ↓44%; IL--‐6 ↓ 62% 
TNF--‐α ↓ 31%; IL--‐18 ↓ 30% 
Monzillo et al, 2003 (101) 24 obese  
BMI 36.7 ± 0.9 
500 kcal/day deficit energy--‐restricted diet and  
moderate--‐intensity exercise 
26 weeks 7.0% of weight IL--‐6 ↓ 41% 
no change in TNF--‐α 
Bruun et al, 2003 (16)  19 obese men, BMI  
38.7 ± 0.7 
1000--‐1480 kcal/day energy--‐
restricted diet 
16 weeks 14.7% of weight IL--‐6 ↓ 24%; TNF--‐α 
↓ 29% IL--‐8 ↓ 30% 
Ziccardi et al, 2002 (181) 56 obese women 
BMI 37.2 ± 2.2 
1300 kcal/day energy--‐restricted diet, increased 
exercise 
12 months 12.6% of BMI Il--‐6 ↓ 47%; TNF--‐α ↓ 31% 
Dandona et al, 1998 (33) 38 obese women 
BMI 35.7 ± 0.9 
925--‐1150 kcal/day energy-restricted diet and 
increased aerobic exercise 
1-2 years 12.3% of weight TNF--‐α ↓ 24% 
  Weight loss surgery: 
Vendrell et al, 2004 (163) 34 morbidly obese 
BMI 49.6 ± 1.0 
Gastric bypass 6 months 30% of weight,  
62% of fat mass 
IL--‐6 ↓ 59%; sTNFR1 ↓ 15%; 
no change in sTNFR2 
Laimer et al, 2002 (83) 20 obese women  
BMI 41.6 ± 1.2 
Adjustable gastric banding 1 years 27% of weight  
45% of fat mass 
CRP ↓ 70%; 
no change in IL--‐6 
Randomized, controlled trials: 
Esposito et al, 2003 (40) 120 obese 
BMI 35.0 ± 2.3 
(v. BMI 34.7 ± 2.4) 
1300--‐1500 kcal/day energy restricted 
Mediterranean--‐ style AHA step I diet (v. 
normal diet) 
2 years 14.7% of weight 
(v. 3.2% of weight) 
CRP ↓ 34%; IL--‐6 ↓ 33% 
(v. no changes in CRP, IL--‐6) 
Nicklas et al, 2004 (102) 316 older adults BMI   
34.5 ±5.4 b± 5.0) 
Behavioral counseling to achieve and keep a 
5% weight loss (v. normal diet) 
18 months 5.1% of weight  
(v. 1.8% of weight) 
CRP ↓ 3%; IL--‐6 ↓ 11%; 
 no change in TNF--‐α  
↓ = significant reduction; CRP = C-reactive protein; IL=interleukin; TNFα = tumor necrosis factor alpha; kcal = kilocalorie, BMI = basal metabolic; AHA= American Heart 
Association  
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Effects of Chronic Exercise on Inflammatory Markers 
Inflammation is a factor of many diseases such as insulin resistance, obesity, 
diabetes and cardiovascular diseases (116). Exercises (aerobic and resistance) has been 
demonstrated to significantly reduce and improve inflammatory cytokine levels (21, 23, 
24, 45, 50, 133). Exercises of this nature remain the most safe, inexpensive, under- 
utilized modality of treatment, readily accessible despite its well-known beneficial 
effects to all humans especially to the obese population. 
Table 2:  Studies demonstrating the association between increased physical activity or physical 
fitness and inflammatory biomarkers in the elderly 
↓ = significant reduction;   = means no change; CRP = C-reactive protein; IL=interleukin; TNFα = tumor necrosis factor alpha; kcal 
= kilocalorie, MET = metabolic equivalent; wk = week; ml = milliliter, kg = kilogram 
 
 
 
There is limited research on the effects of exercise on inflammatory marker such 
as IL-6 and TNF-α. However the mechanisms by which exercise training influences 
changes in inflammatory marker are not fully known and needs to be studied. The initial 
cytokines in the cytokine cascade are IL-6, IL-1, and TNF-α (124). These cytokines may 
increase up to 100 fold during intense exercise (116, 119, 124). A study (22) was 
conducted on subjects who completed a 30-min cycle ergometer at 60% of peak oxygen 
Reference N Age Activity or Fitness Measure Inflammatory Markers 
Taaffe et all, 
2000 (149) 
880 74.3 ±2.7 Time in moderate or strenuous 
activity (hr/yr) 
 ↓CRP (43.8%),   ↓IL-6 
(39.1%) 
Reuben et al., 
2003 (135) 
870 74.3 Modified Yale Physical Activity 
Survey (kcal/min) 
↓ CRP (47.4%),    
↓IL-6  (44.2% ) 
Colbert et al., 
2004 (26) 
2964 70-79 Time and duration spent activity 
over previous year (kcal/kg/wk) 
↓ CRP (27.8%),   
↓ IL-6 (21.1%),  
↓ TNFα (6%) 
Elosua et al., 
2005 (38) 
1004 65 or older Time spent in light and moderate 
activity 
↓CRP (70%), ↓ IL-6 (20%)    
Men    ↓TNFα 
Women  =  TNFα 
Yu et al., 2009 
(177) 
3289 50-70 International Physical Activity 
Questionnaire (MET-hr/wk) 
  ↓CRP (19.6%),      
=  TNFαRII,      
=   IL-6 
Valentine et al., 
2009 (162) 
132 70 ± 5.4 VO2 Peak (ml/kg/min) ↓ CRP men   (6.6%)   
 =  CRP women   
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up-take, 3 day/wk for 8 wk and reported that IL-6 concentration following the 30 bouts 
of cycle ergometer increased significantly 30 min post-exercise by 13%, stayed elevated 
2 h post-exercise by 9% and returned to baseline 3 h post exercise and TNF-α 
concentration decreased significant by -16% 2 h and -39.5% 3 h post-exercise (22). 
Another study done by Keller and colleagues (68, 69) isolated nuclei from muscle 
biopsies obtained from subjects who completed a 60-min cycling exercise at about 70% 
of their maximum work load on day 1 and two-legged knee extensor at about 60% of 
their maximum work load for 180 min of cycling exercise on day 2 demonstrated that 
the transcription rate for IL-6 rapidly increases 40 fold after 90-min and about 60 fold 
after 180 min of exercise and concluded that exercise activates the transcription of the 
IL-6 gene in skeletal muscles (68). Niebauer et al (104) evaluated the effects of 8 weeks 
of exercise training consisting of a 5 d/wk submaximal cycle ergometer (30 min/d) and 9 
min/d of calisthenics exercises on cytockines. They reported that exercise program had 
no effect on IL-6 but VO2max was increased by about 3ml/kg/min. Timmerman et al 
(157) conducted a 12-week training study involving endurance exercise (3 d/wk for 20 
min at 70-80% heart rate reserve) and resistance exercise (8 exercises, two sets at 70-
80% of one repetition maximum). They reported that there was a significant time effect 
driven by a 41% decrease TNF-a production and a 64% reduction in inflammatory 
monocyte in the physical inactive group.   
Obese individuals usually have high levels of some these cytokines which has 
been associated with chronic low-grade inflammation (36, 91, 95). Exercising regularly 
helps reduced body weight and pro-inflammatory cytokines (113). For example, 
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Ostrowski et al (113) investigated the time course of prolonged strenuous exercise on 
inflammation in marathon runners with a median running time of 3 h and 26 min and a 
median VO2max of 61.2ml/min/kg. They reported that the mean plasma concentration of 
IL-6 decreased significantly to about 20-fold 4 h post exercise. They concluded that 
strenuous exercise (marathon race) induces anti-inflammatory cytokine action during 
exercise. Other studies have also shown same anti-inflammatory effects during exercise 
(113, 116).  For example Dekker et al (36) examined obese men who performed a 60 
min aerobic exercise (jogging, walking on treadmill at about 60% VO2max), 5 times/wk 
for 12 wk. They reported a 17% reduction of IL-6 in the obese as a result of exercise 
training. During exercise IL-6 is produced by the muscles and adipose tissue and can 
stimulate the production of other anti-inflammatory cytokines such as IL-10, IL-1ra and 
turns to inhibit the production of TNF-α a pro-inflammatory cytokine (124, 137, 146). 
Another study demonstrated that exercise induces the transcription of metabolic genes in 
skeletal muscles (120). The exercise-induced production of IL-6 that may be involved in 
mediating the reduction of TNF-α production and other plasma cytokines, suggesting 
that exercise induces a strong anti-inflammatory effect in human subjects (42). Another 
study conducted by Keller and associates (69) evaluate the transcription levels of IL-6 
during exercise. They measured IL-6 level on subjects who performed an incremental 
cycle ergometer maximal exercise test.  The researchers found that IL-6 levels increased 
6.49-fold throughout the exercise bout and decreased during recovery (69).  
Other studies have shown that the IL-6 gene transcription located in the muscles 
and adipose tissue is released during exercise in high amounts into blood (42, 68, 69, 
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116, 121). The IL-6 level during exercise increases dramatically (up to 100 fold) and the 
increased levels of IL-6 has been consistently shown in many research studies (17, 21, 
23, 24, 45, 66, 68, 89, 105, 106, 116, 118, 120-124, 145, 146). Endurance training can be 
very helpful in reducing inflammation. Scheett et al, (142) evaluated the effects of 90-
min of aerobic-type training consisting of running, jumping, aerobic dance, 50% team 
sports and 50% running games interspersed through 3 h each day, 5 d/wk on 
inflammatory markers. The researchers reported that training resulted in a significant 
increase in TNF-α33.9% compared to control and an increase in IL-6 15.3% in training 
but not significant. Adamapoulos et al (5) also showed that exercise training (cycling 5 
d/wk for 30 min/d at 60% to 80% maximal heart rate) resulted in a significant reduction 
in TNF-a by -38.7% (2.9 pg/ml) and IL-6 by -28.9% (2.4 pg/ml). Rall et al, (134) 
conducted another study to examine the effects of resistance training (strength training) 
(3 sets of 8 repetitions on 5 different machines (abdominal and back extension), upper 
body (chest press), and lower body (leg press and leg extension) strength with a 2 min 
rest between each set for about 45 min 2 times a wk). Each session was preceded by a 
warm-up period consisting of approximately 15 min of water exercises (calisthenics and 
10 min of water walking). They reported that resistance training had no significantly 
difference on IL-6 and production of secreted TNF-α at baseline was 50% greater among 
exercisers.  
Fischer et al, (45) evaluated the effect of glycogen mediated exercise-induced 
increase in IL-6 mRNA on subjects who performed a power max test starting with a 60 
knee extensions/min at 30 W followed by an incremental increase of workload by 10 W 
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every 2 min until volitional exhaustion. A  second test evaluated at a workload of about 
90% of power max for 10 wk, 5 times/wk during a 1 h training session and  reported that 
mRNA IL-6 increased from 20-210-fold following their endurance training compared to 
no change in control. Their data was consistent with an earlier theory developed that the 
transcription of the IL-6 gene is regulated by glycogen depletion since carbohydrate 
ingestion during exercise does not attenuate the rate of muscle glycogenolysis (69, 130, 
131).  Ho et al, (64) conducted a study to look at the effects of chronic exercise training 
on markers of inflammation in overweight and obese individuals. Their exercise 
intervention involved a 30 min aerobic exercise on a treadmill at 60% heart rate reserve. 
A 30 min resistance exercise, 4 sets of 8-12 repetitions at 10-RM level of leg press, leg 
curl, bench press and rear deltoid row with each set completed in about 30 s with 1 min 
rest in between each set or a combination of 15 resistance (2 sets of the above) and 15 
min aerobic exercises for a duration of12 weeks. From their evaluation, they reported 
that exercise significantly decreased TNF-α by 20.8% in the aerobic group and 32.6% in 
the resistance group and by -22.6% in the combination group and no significant changes 
in IL-6 levels after 12 weeks in all groups. Physical exercise training has been shown to 
lower levels of inflammatory makers (63, 64, 172, 174, 175). Aerobic exercise training 
has been demonstrated to significantly reduce and improve inflammatory cytokine levels 
(10, 36, 64, 102, 172, 174, 175). A study performed by Pedersen and associates (115)  
done on young healthy subjects who performed a 3 h dynamic two-legged knee extensor 
exercise at about 50% individual maximum power output showed a moderate increase in 
heart rate from about 113-122 beat/min and a 16-fold increase in mRNA IL-6 and a 20-
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fold increase in plasma IL-6 (115). Same model was applied to older healthy untrained 
adults and they showed an even higher amount of IL-6 at same relative intensity (115). 
A training exercise program that combines two or more different forms of exercises in 
one movement to stimulate large amounts of muscles, increase VO2max, change body 
composition and induce changes in inflammatory markers can be very beneficial for the 
obese population. Table 3 shows some selected studies on the effects of exercise training 
on inflammatory biomarkers. Table 3 shows evidence from some intervention studies 
showing the association between physical activity and inflammatory markers. 
 
Table 3: Selected studies showing the effect of exercise training on inflammatory biomarkers in the 
elderly  
  ↓ = significant reduction; = means no change; CRP = C-reactive protein; IL=interleukin; TNFα = tumor necrosis factor alpha; kcal 
= kilocalorie, MET = metabolic equivalent; RPE = rate of perceive exertion; wk = week; kg = kilogram 
 
 
 
Effects of exercise training and diet-induced weight loss on these markers 
  Despite the complexity of inflammatory cytokine gene transcription, the key 
interventions in treating obese patients remains to moderate caloric restriction, moderate 
Reference N Age Duration Exercise Intervention Inflammatory 
Marker 
Nicklas et al., 
2004 (102) 
67 
70 
69±6 
69±6 
18month 1 hour, walking 50-75% HRR and lower 
body resistance training with weighted 
cuff, 3x/wk 
↓CRP 3% 
↓IL-6 11%,  
↓TNFα 2% 
Hammett et 
al., 2004 (61) 
30 
31 
66±4 
67±5 
6month 45min, aerobic training estimated 80% of 
VO2 Max, 4x/wk (3x supervised, 1x 
unsupervised) 
=   CRP 
Kohut et al., 
2006 (78) 
48 
49 
69.8±5.5 
70.3±4.6 
10month 45min, aerobic exercise class at up to 65-
80% VO2 peak, 3x/wk 
↓ CRP (35.3%),  
↓ IL-6 (33.3%) 
Nicklas et al., 
2008 (103) 
183 
186 
76.4±4.1 
77±4.4 
12month 150min/wk, walking at RPE 12-13, 
resistance training RPE 15-16 
↓ CRP (32%),  
↓IL-6 (16%) 
Vieira et al., 
2009 (166) 
66 
61 
70±.8 
70±.6 
10month 45-60 min, 60-70% VO2 Max, 3x/wk  ↓ CRP 
Campbell et 
al., 2009 (20) 
53 
62 
60.5±7 
60.9±6.8 
12month 45min, 60-75% HR max 5x/wk (3x 
supervised, 2x unsupervised) 
↓ CRP (10%),  
= IL-6 
Beavers et al., 
2010 (12) 
182 
186 
76.4±4.1 
77±4.4 
12month 150 min/wk walking goal at RPE 12-13, 
resistance training at RPE 15-16 
 =TNFα 
=  IL-6sR 
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exercise, 5%-10% weight loss, prevention and treatment of co-morbid conditions 
associated with obesity (114, 139, 140). Numerous studies have shown the high increase 
of IL-6 during at the onset exercise and how the IL-6 gene expression from contracting 
muscles can affect metabolic and physiological function during training (17, 18, 116, 
118, 171). Exercise and diet increases the transcription of inflammatory markers (102).  
A study was conducted by Nicklas and colleagues (53) on 316 overweight or obese 
subjects for 18 months. These subjects were randomized into four 18-mo treatments (a 
healthy control, diet-induced weight loss, exercise and diet plus exercise groups).  These 
subjects participated in a 3 d/wk exercise program consisting of 15 min aerobic exercise 
and a 15 resistance exercise portion consisting of 2 sets of 12 repetitions of the following 
exercises. The exercises they performed were leg curl, leg extensions, heel raise, and 
step ups at a 50-75% heart rate reserve. Cuff weights and weights vest were used to 
provide resistance. They reported that the diet-induced weight loss group observed 
significantly greater reduction in IL-6 by 11% (p=0.009) and TNF-α 2% (p=0.007) than 
all the other groups with no significant changes (53). A study conducted by You et al 
(175) sought to determine whether a hypocaloric diet with and without exercise training 
is effective in reducing IL-6 and TNF-a levels and whether these markers are related to 
changes in regional lipolysis in obesity for 6-mo on 50 women.  They reported that diet 
plus exercise and not diet alone significantly decreased plasma levels of IL-6  27.1% and 
TNF-a decreased by -6.4% and that changes in IL-6 ( r = 0.37) were correlated to 
changes in body weight. There were no significant relationships between changes in 
inflammatory markers and changes in fat, fat free mass percent body fat and visceral fat 
 28 
 
 
area. They then concluded that a modification of chronic inflammation is associated with 
changes in local adipose tissue metabolism in response to diet and exercise (175). Tsukui 
and co-workers (41) conducted a 5-month longitudinal intervention training program 
(30-45 min/d/wk, 4-5 d/wk at 40-50% of their VO2max) on 41 women. They 
demonstrated that regular exercise significantly decreased body weight, decreased BMI, 
percent body fat, serum TNF-α from 9.0 to 1.5 pg/ml (41). Table 4 summarizes some 
studies that had been done to show that effects of weight loss and exercise training on 
inflammatory marker. 
 
Table 4: Shows a summary of studies on the effects of weight loss and exercise training on markers 
of inflammation. 
 
Study, year 
No. of 
participants Duration 
Effects on body composition 
and aerobic fitness/physical 
function 
Effects on 
Inflammation  
Kohut et al, 
2006 (78) 97 older adults 10 months Aerobic exercise versus control   ↓ CRP (-35.3%), 
      = body weight ↑maximal METs  ↓ IL-6 –(33.3%),  
Olson et al, 2007 
(111) 28 overweight or   Control: =body weight, =fat mass,  =CRP, 
  obese women 12 months  =lean mass, exercise: =body weight  =IL-6 
       =fat mass, ↑ lean body mass ↓  CRP (9%), =IL-6 
Nicklas et al, 
2008 (103) 369 older adults 12 months Exercise versus control: =body  ↓CRP (32%), 
      weight, =fat mass ↓ IL-6 (16%) 
Campbell et al, 
2009 (20)  115 overweight    
Exercise versus control:  
↓ body fat,  ↓ CRP (10%), 
  or obese 12 months ↑  VO2max  =IL-6 
Donges et al, 
2010 (37) 102 adults 10 weeks Aerobic exercise versus control: 
↓CRP (16.1%),  
 =IL-6 
      
↓ body weight;  
resistance exercise versus control: 
=body weight 
↓CRP (32.8%), 
 =IL-6 
↓ = significant reduction; ↑= significant increase = means no change; CRP = C-reactive protein; IL=interleukin; TNFα = tumor 
necrosis factor alpha; MET = metabolic equivalent.  
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Effect of Exercise and Diet on microRNAs and NF-kB Expression 
MicroRNAs remain potent targets to many cells that are very sensitive to up or 
down regulation of microRNAs expression (54). The microRNAs in NF-kB signaling 
pathway (90) in cells of obese individual may provide a potential progression and 
maintenance that might pave the way towards the translation of microRNA-based 
therapeutic (90) and clinical chemistry to improve on obesity and other metabolic 
diseases that are affecting millions of people around the world. Chen and colleagues (25) 
reported in a research study that the level of microRNA in serum are stable, reproducible 
and consistent among individual of the same species (25). They sequenced all serum 
microRNA from healthy Chinese subjects and reported that 100 and 91 serum 
microRNAs are found in male and female subjects respectively (25). They also 
identified specific expression patterns among serum microRNAs for diabetes and cancer, 
providing evidence that serum microRNAs contain fingerprints of numerous diseases 
(25). microRNAs may be very related to an individual’s body immune system and their 
alteration may very much and may reflect an inflammatory response shared by various 
diseases such as in overweight, obesity, diabetes and cancer (25, 39, 54, 90). It is unclear 
whether insulin-resistant and obese human subjects have abnormal NF-kB activity in 
muscle (153).   
The nuclear factor-kB (NF-kB) a transcriptional factor that regulates genes is a 
protein dimer reticuloendotheliosis (Rel) (90) that can bind on a DNA sequence on the 
kB site. The transcription factor NF-kB was first discovered by David Baltimore in 
1986. The NF-kB pathway is known to be activated by many stimuli including cytokines 
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(13, 59). Pro-inflammatory cytokines such as IL-6, TNF-α, IL-1 and IL-8 are produced 
upon the activation of NF-kB. The activation of NF-kB plays a major role in the 
inflammatory response and regulation to inflammatory stimulus. It is an effector present 
in the cytoplasm and when activated, it is translocated to the nucleus where it induces 
gene transcription (13). The microRNAs target genes encoding NF-kB regulators and 
effectors in the NF-kB signaling pathway with the microRNAs participating in a positive 
or negative feedback (90). It is very challenging targeting microRNAs that are effectors 
of NF-kB using chemical inhibitors but it remains to be ascertained whether 
dysregulation of microRNAs (25) rather than NF-kB activation is a causal to obesity and 
other metabolic diseases and their progression.  
The effect of exercise on inflammation can’t be very well understood without 
studying the molecular pathways linking exercise training to inflammation (96, 130, 153, 
165). Every time the body moves, the muscles releases signaling molecules that 
communicate with the rest of the body to coordinate and regulate different mechanisms 
associated with exercise (151, 153). Tantiwong et al (153) measured NF-kB DNA-
binding activity and the mRNA level of putative NF-kB-regulated myokines such as IL-
6 and MCP-1 in muscle samples from type 2 diabetes mellitus (T2DM), obese, and lean 
subjects before (0 min), during (40 min), and after (210 min) bout of cycling exercise 
training. At baseline, NF-kB activity was elevated 2.1-fold and 2.7-fold in obese, 
nondiabetic and T2DM subjects, respectively. NF-kB activity was increased 
significantly at 210 min following exercise training in lean (1.9-fold) and obese (2.6-
fold) subjects, but NF-kB activity did not change in T2DM. Exercise training increased 
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MCP-1 mRNA levels significantly in the three groups, whereas IL-6 gene expression 
increased significantly only in lean and obese subjects. MCP-1 and IL-6 gene expression 
also peaked at the 40-min exercise time point (153). Their result indicated that exercise 
affect changes in signaling molecules and inflammatory cytokines. Inflammation 
resulting from oxidative stress, free radical species may be attenuated by chronic 
exercise through the activation of factors such as NF-kB mediated gene expression 
during exercise training (59, 90). During exercise training signaling molecules are 
released that stimulate unique healing responses that couples both pro-inflammation and 
anti-inflammation mechanisms to regenerate and repair and grow stronger tissues and 
communicates with to the rest of the body and provides instructions to the body how to 
function, control and regulate inflammation (116, 118-121).  
Exercise that is normally performed at high intensities has an anabolic stimulus 
that may increases the synthesis of contractile and structural proteins and also specific 
protein that may affect microRNA gene regulation (57). The recent identification of 
microRNAs has been helped to show the role of microRNA expression during exercise 
(87, 133, 168). Lui et al (87) investigated the microRNAs associated with PTEN 
signaling pathway on cycling exercise training. They conducted a study on subjects 
performed a cycling exercise training 5 d after spinal cord transfection. The training 
included a 5 d/wk of 30 min per session at 45 rpm for either 10 d or 31 d. They reported 
changes in the expression of microRNAs and target mRNA. Their conclusion was that 
exercise significantly increased microRNA-21 at 10 d (p<0.0001) with a significant 
decrease in PTEN (p<0.05).  They also reported a 50% decrease in microRNA 15b with 
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no change of microRNA 21 at 31days (87).  Another study (9) investigated the role of 
microRNA 146a on inflammation on 20 type 2 diabetes subjects. They reported that 
microRNA 146a level was significantly decreased by 37.5% and the target genes TRAF6 
and NF-kB significantly increased by 61.2% and 59.8% respectively with an increase 
trend in IL-6 and TNF-a levels in these patients with no statistical significance (9).   
Baggish et al (8) conducted a study to investigate the effect of microRNA in 
response to acute exhaustive cycling (a 1 min of unloaded exercise 0 W/min and 
workload was increased by 25 W/min until volitional exhaustion) before and after a 90 d 
training period at a respiratory exchange ratio value > 1.1 and at a heart rate of at least 
90% of age-predicted maximum and sustained rowing exercise training on inflammatory 
microRNA 21 and 146a for a period of 90 d. These subjects also performed a 5 km 
distance of team-based rowing, an indoor ergometer session for 1-3 h at low stroke rates 
(20-24 strokes/min between the 9 d period. They reported a microRNA-146a 3.05-fold 
and microRNA 21 2.63-fold changes with the sustained exercise training and about a 
7.5-fold and 3.16-fold change in microRNA-146a and microRNA-21 respectively with 
acute exercise. MicroRNA expression of human adipose tissue can be correlated with 
adipocyte phenotype, and obesity parameters (35). A global microRNA expression 
micro array of about 723 human and 76 viral mature microRNAs in human adipocytes 
were studied in subcutaneous fat and during differentiation from non-obese and obese 
women with and without type 2 diabetes. Study report by Ortega and associates (112) 
revealed that 50 microRNAs (6.2%) were significantly different between lean and obese 
subjects, 70 microRNAs (8.8%) were significantly and highly up or down-regulated in 
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adipocyte compared to pre-adipocyte, 17 microRNAs (2.1%) were correlated to 
anthropometrical and metabolic parameters (BMI and fasting glucose and triglycerides) 
and 11 microRNAs (1.4%) were significantly down-regulated in subcutaneous fat from 
obese subject with and without type 2 diabetes. They concluded that microRNAs may 
represent biomarkers and therapeutic targets for obesity and obesity-related 
complications (112).  
Relationship between microRNAs and Inflammation (microRNA-inflammation) 
The response to inflammation comprises of complex physiological and metabolic 
reactions that requires integration between all human systems and biomolecules 
including cytokines (109, 110). The evidence of circulating inflammatory cytokines and 
microRNAs provides a tissue specific area in research that can help understand the 
intercellular and intra-organ biochemical mechanisms or pathways (14, 109, 110, 128, 
150). Evidence also indicate that microRNAs (9, 14, 75, 109, 110, 128, 150-152) can 
activate or inhibit inflammatory cytokines which relates to activating anti-inflammatory 
mechanisms to counter pro-inflammatory signals such as the NF-kB pathway to prevent 
cell and tissue damage (110). The microRNA based anti-inflammatory mechanisms in 
research may provide evidence that microRNAs are involved in regulating inflammation 
with prototype such as microRNA-21 and microRNA-146a (128). In physiological 
conditions, the transcription of microRNA 21 and 146a is at baseline levels and can 
initiate pro-inflammatory signals which can immediately result in a co-induction of their 
expression largely dependent on NF-kB pathway (14).  
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Evidence from a few studies indicates that microRNAs are delivered into blood 
and might be susceptible to degradation by extra-cellular RNAses and some studies have 
shown that microRNAs are secreted into the bloodstream either through micro-vesicles 
or in exosomes (14, 109, 110, 128). Olivieri et al (109)  showed that there is a positive 
correlation between microRNA 21 and markers of inflammation such as CRP. 
Balasubramanyam et al (9) showed in one of their studies that reduced microRNA 146a 
levels were reported in blood cell of Asian Indian patients with type 2 diabetes in 
association with insulin resistance, poor glycemic control, specific pro-inflammatory 
cytokine genes and high levels of TNF-a and IL-6. Most microRNAs targeting NF-kB 
pathway affects the NF-kB signaling through a negative feedback mechanism that is 
aimed at restraining or reducing the excessive pro-inflammatory response induced by 
signaling activation (14).  
MicroRNA are not only important for normal development and physiology but 
also for important in the pathologies of obesity, diabetes, cardiovascular diseases and 
inflammation. An altered expression of microRNA targeting the NF-kB pathway may 
contribute to the dysregulation of anti-inflammation and microRNA are an important 
modulator of the immune function. For example microRNA-146a has been shown to 
inhibit the expression of its target gene TRAF6 , impair NF-kB activity and suppress the 
expression of NF-kB target genes such as IL-6, Il-8, and TNF-α (65, 109, 110, 150). A 
study was conducted by Balasubramanyam et al (9) on 20 subjects in South India. The 
study comprised of two groups of subjects who were confirmed by oral glucose 
tolerance test (OGTT) to have a 2 h plasma glucose value >11.1 mmol/l (200 mg/dl) 
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based on WHO and were diagnosed with type 2 diabetes and reported that microRNA 
146a was significantly decreased (p<0.001) with type 2 diabetes, TRAF6 mRNA levels 
was significantly increased (p<0.015) with type 2  diabetes and NF-kB expression was 
also significantly increased (P=0.007) with type 2 diabetes with an increase trend in 
TNF-α and IL-6 levels in patients with type 2 diabetes. They reported that the 
microRNA 146a was negatively correlated to TRAF6, NF-kB mRNA levels and 
circulating levels of TNF-α and IL-6. Emerging evidence suggest that microRNAs play a 
significant role in adipocyte differentiation and the identification of tissue specific 
microRNAs implicated in obesity might help in future studies to understand and develop 
new strategies for early diagnosis and therapeutic prevention and intervention of obesity-
related complication (35). Targeting microRNAs such as microRNA 21 and 146a and 
many others that are related to obesity, their target genes such as PTEN and TRAF6 and 
the mRNAs of (PI3K/AKT/NF-kB), TNF-α and IL-6 will provide a break-through in 
solving complicated diseases such as obesity.  
 
Conclusion 
The obese population is currently one of the fastest growing segments in United 
States and around the world. Due to the high prevalence of obesity, it has been estimated 
that almost a third of health care expenditures is for overweight and obesity treatment. 
There are numerous research studies about obesity and weight maintenance, but it has 
yet to be determined what the ideal weight loss and exercise program, diet and caloric 
percentages is needed for the obese population. Obesity is related to inflammation.   
Exercise causes an acute increase in inflammatory markers that is mediated to some 
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degree during training. Exercise and strenuous activity have been shown to increase 
blood IL-6 and TNF-α, but regular exercise is believed to attenuate the increase in these 
inflammatory markers. Weight loss has also been shown to reduce markers of obesity.  
The purpose of this study is to examine the combined effects of exercise and diet-
induced weight loss on markers of health and fitness, inflammation, microRNA, and 
gene expression related to NF-kB signaling pathway. The results of this study will 
provide additional data evaluating whether exercise and diet-induced weight loss affects 
inflammatory cytokine gene transcription, microRNAs gene expression and NF-kB 
signaling pathway. Obesity is associated with inflammation and we believe that our 
exercise and diet-induced weight loss program may reduce these makers. This study will 
compare results of the overweight /obese population to control group only. 
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CHAPTER III 
METHODS AND MATERIALS 
Experimental Design 
Table 5 below shows the general research design and time course for assessments 
and an overview of the research design and the testing schedule for our 12 wks study 
program. Data for this study were obtained from a large comparative effectiveness study 
evaluating different weight loss program approaches.  Participants were randomized into 
a non-exercise and non-diet control or an exercise and weight loss program for 90-days.  
The study included a baseline testing session followed by 3 additional testing sessions 
(0, 4, 8, 12 wk).  Exercise testing occurred during the baseline and 12 wk sessions. The 
independent variable was exercise and diet-induced weight loss intervention program. 
Dependent variables were:  body composition (body weight, fat mass, fat free mass and 
body fat percent), clinical white blood cells and serum profiles for microRNAs (miR21 
and miR146a) and mRNA of IL-6, TNF-α, and the mRNAs of PTEN, TRAF6, PI3k, 
AKT and  NF-kB; maximum repetition 1(RM) and 80% 1RM isotonic strength.    
Participants 
Eighty-two (82) sedentary, overweight/obese women participants (BMI > 27) 
between the ages of 18-65 were recruited to participate in this portion of the study.   
Participants were not be allowed to participate in the study if they had any uncontrolled 
metabolic disorder, known electrolyte abnormalities, heart disease, arrhythmias,  
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Table 5: Effects exercise and diet-Induced weight loss in overweight women on characterization of 
serum/white blood cells on microRNAs and cytokine gene transcription–Overview of research 
design and testing schedule 
 
 
Familiarization 
and Entry 
(T0) 
 
Baseline  
(T1) 
 
4 weeks 
(T2) 
 
8 weeks 
(T3) 
 
12 weeks 
(T4) 
 
Phone interview  
 
Familiarization 
session 
 
Complete of 
paper work  
 
Review medical 
history 
 
Randomization 
into exercise and 
diet-induced 
weight loss and 
control programs 
 
 
High Protein Diet 
Review 
 
 Body Weight 
 
Blood collection 
(white blood 
cells/serum) 
 
Dual Energy  
X-ray 
Absorptiometry 
(DEXA) 
 
Graded Exercise 
Testing (GXT ) 
 
1RM at 80%  
1RM Isotonic 
Bench and 
Isotonic Leg Press 
 
30 minutes 
Resistance 
Exercise/Zumba  
4 times/week 
 
 
High Protein Diet 
Review 
 
 Body Weight 
 
Blood collection 
(white blood 
cells/serum)  
 
Dual Energy  
X-ray 
Absorptiometry 
(DEXA) 
 
30 minutes 
Resistance 
Exercise/Zumba  
4 times/week 
 
 
 
High Protein Diet 
Review 
 
 Body Weight 
 
Blood collection 
(white blood 
cells/serum) 
 
Dual Energy  
X-ray 
Absorptiometry 
(DEXA) 
 
30 minutes 
Resistance 
Exercise/Zumba  
4 times/week 
 
 
High Protein Diet 
Review 
 
 Body Weight 
 
Blood collection 
(white blood 
cells/serum) 
 
Dual Energy  
X-ray 
Absorptiometry  
(DEXA) 
 
Graded Exercise 
Testing (GXT ) 
 
1RM at80%  
1RM Isotonic 
Bench and 
Isotonic Leg 
Press 
 
30 minutes 
Resistance 
Exercise/Zumba  
4 times/week 
 
 
 
diabetes, or thyroid disease; a history of hypertension, hepatorenal, musculoskeletal, 
autoimmune, or neurological disease. Participants were not allowed if they were taking 
any hypoglycemic, or androgenic medications; and/or, if they had taken ergogenic levels 
of nutritional supplements that may affect muscle mass (e.g., creatine, HMB), 
anabolic/catabolic hormone levels (e.g., DHEA), or weight loss (e.g., thermogenics) 
within three months prior to the start of the study. Participants with a controlled medical 
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condition had their physician complete and sign a physician consent form prior to 
participation in the study. Participants that meet eligibility criteria into our study 
program were informed of the requirements of the study and sign consent statements in 
compliance with the Human Participants Guidelines of Texas A&M University and the 
American College of Sports Medicine.  
Study Site 
All familiarization and testing was conducted at the Exercise & Sport Nutrition 
Laboratory (ESNL) in the Department of Health, and Kinesiology at Texas A&M 
University. Exercise training was conducted at the Exercise & Sport Nutrition 
Laboratory (ESNL) in the Department of Health and Kinesiology at Texas A&M 
University. Assays were conducted at the Institute of Obesity and Cancer research 
Laboratory at Texas A&M University.    
Entry and Familiarization Session 
Participants expressing interest in the study were interviewed by phone to 
determine whether they are qualified to participate. The participants who met the 
eligibility criteria were invited to attend a familiarization session. During this session 
participants received verbal and written explanation of the study protocol and design. 
Participants also received testing procedures, blood collection procedures and were 
introduced to the equipment that would be used throughout the entire study 12 wk. 
Randomization and Dietary Intervention 
Participants were then randomized according to body mass index (BMI) and age 
into either an exercise and diet-induced weight loss (E) group or a control (C) group.  
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Participants were given an appointment time to perform baseline assessments and three 
other sessions as summarized in table 5. 
Training Protocol 
Participants randomized into the exercise and diet-induced weight loss group 
(EX) followed the Curves™ training program while participants in the control group (C) 
followed their normal eating and daily activities with no exercise. The physical training 
protocol included three regular resistance workouts each week for 12 weeks and one 
Zumba dance workout, while maintaining a greater than 90% compliance record (43 out 
of 48 workouts). The circuit training utilized the computerized CurvesSmart system 
(Curves International, Waco, TX, USA) equipped with software designed by MYTRAK 
(version 4.2.1, copyright 2004-2011, MYTRAK Health System Inc, Mississauga, Ontario, 
Canada). The circuit training consisted of 13 bi-directional hydraulic resistance exercise 
machines that worked all major muscle groups (i.e., elbow flexion/extension, knee 
flexion/extension, shoulder press/lat pull, hip abductor/adductor, chest press/seated row, 
horizontal leg press, squat, abdominal crunch/back extension, chest flies, oblique, 
shoulder shrug/dip, hip extension, and side bends). During the circuit training, subjects 
were instructed to complete as many repetitions as possible during a 30 second time 
period on each resistance machine. Between machines, subjects performed floor-based 
aerobic exercises or stepping exercise designed to maintain an elevated heart rate. 
Subjects performed the entire circuit twice during the 26 minute regular circuit workout. 
During the Curves Zumba workout, subjects performed 1 minute of Zumba dance moves 
taught by a certified Zumba instructor and all circuit training sessions were supervised 
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by trained fitness instructors who assisted subjects with proper exercise technique and 
self-monitoring of heart rate in order to maintain an exercise heart rate between 60-80% 
of target heart rate using age-predicted maximal heart rate (220-age). They were also 
encouraged to walk for 30 min at a brisk pace at 60-80% of heart rate reserve on one of 
the days they were not using the curves equipment. Subjects also performed 4 minutes of 
whole body stretching following circuit workouts. The circuit training equipment was 
located in the Exercise and Sports Nutrition Laboratory at Texas A&M University. 
Diet Intervention 
  In concurrence with this plan, subjects followed the Curves Phase I higher 
protein weight loss diet (1,200kcals/day) for one week and the phase II higher protein 
weight loss diet (1,500kcals/day) for 11 weeks. The macronutrient content for both 
phases I and II diets was 45% protein, 30% carbohydrate, 25% fat.  A registered dietitian 
at the Exercise and Sports Nutrition Lab of Texas A&M University reviewed the higher 
protein diet (HPD) and exercise plan with subjects and provided them with the Curves 
Fitness and Weight Management Plan (62), the Curves Food & Exercise Diary (30) and 
Curves Essentials 2 go dietary supplements. Participants were encouraged to consume of 
Curves multivitamins and minerals containing 800 mg of calcium and 520 mg of 
Omega-3 fatty acids daily with food (Curves International, Inc. Waco, TX). The dietitian 
also met with subjects weekly throughout the study to discuss any dietary challenges or 
concerns. The Curves Fitness and Weight Management Plan dietary intervention 
protocol is summarized in Table 6. 
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Table 6:  Overview of diet assignments  
 
Diet 
Period 
 
               Group 
Macro- 
nutrient 
Grams/ 
Day 
Kilocals/ 
Day 
Percent  
Daily Diet 
(%) 
Dietary 
Phase 
                   Exercise and Diet-Induced Weight Loss (EX) Group) 
n = 29 
 
Phase I 
(1 Week) 
 
1,200 kcals/d 
 
 
HPD + 
Exercise 
 
PRO  
CHO 
FAT  
 
 
 
135  
90  
33   
 
 
 
540  
360  
300   
 
 
 
45  
30  
25   
 
 
 
Phase II 
(11 weeks) 
 
1,500 kcals/d 
 
 
 
HPD + 
Exercise 
 
PRO  
CHO 
FAT  
 
  
 
 
169 
113  
42   
 
 
 
675 
450  
375  
 
  
 
 
45  
30 
25   
 
 
 Control ( C) Group 
n = 20 
Baseline to 
12 Weeks 
Normal Diet 
Normal Activity 
No Exercise 
 
None 
 
None 
 
None 
 
None 
 
 
Testing Methods 
Test sessions 
Participants were instructed to refrain from exercise for 48 hours and fast for 12 
hours prior to baseline testing. Baseline (0 wk) testing sessions and the 12 wk testing 
sessions were identical and different from the testing sessions of 4 wk and 8 wk that 
were also identical as shown in Table 5.  Participants reported to the ESNL for body 
composition and clinical assessments. Once they reported to the lab, participants 
completed a radiation questionnaire.  Participants were weighed, had body composition 
determined using Dual Energy X-ray Absorptiometry (DEXA); donated blood samples, 
performed a cardiopulmonary symptom-limited maximal exercise stress test; and, 
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performed 1 repetition maximum (RM) and 80% of 1RM on the isotonic bench press 
and leg press. 
Body composition  
Height was measured using standard anthropometry. Total body weight was 
measured using a Healthometer (Bridgeview, IL, USA) self-calibrating digital scale with 
a precision of +/-0.02 kg.   Body composition (excluding the cranium) was determined 
using a Hologic Discovery W QDR series DEXA (Hologic Inc, Waltham, MA, USA) 
equipped with APEX software (APEX Corporation Software, Pittsburgh, PA, USA). 
Participants were informed of any or all inherent risks that could come from the 
radiation exposure and completed a radiation exposure questionnaire prior to all scans. 
Quality control (QC) calibration procedures were performed on a spine phantom 
(Discovery W-CALIBER Model DPA/QDR-1 anthropometric spine phantom) prior to 
each testing session.  The DEXA has been validated as an accurate method for body 
composition assessment (55, 77, 97, 147). The mean test-retest reliability of studies 
performed on some male athletes with this Hologic system yielded mean coefficients of 
variation for total bone mineral content and total fat free/soft tissue mass of 0.31% to 
0.45% with a mean intra-class correlation of 0.985 (6).    
Cardiopulmonary exercise tests 
Cardiopulmonary exercise tests were performed at baseline and 12 weeks in 
accordance to standard procedures described by the American College of Sports 
Medicine’s (ACSM) Guidelines for Exercise Testing and Prescription (4). The Nasiff 
Cardio Card electrocardiograph (Nasiff Associates, Inc, Central Square, NY, USA) was 
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used to assess heart function using a standard 12-lead arrangement (4).  
Cardiopulmonary measurements were assessed using a Parvo Medics TrueMax 2400 
Metabolic Measurement System (ParvoMedics, Inc., Sandy, UT).  The participants 
performed the Bruce or modified Bruce treadmill protocol (148) following the speeds 
and inclination grades of the Parvo Medics TrueMax 2400 Metabolic Measurement 
System (ParvoMedics, Inc., Sandy, UT).  Heart rate (HR), electrocardiograhic tracings, 
and expired gases were monitored continuously throughout the exercise test.  Blood 
pressure (BP) and ratings of perceived exertion (RPE) were obtained toward the end of 
each stage. The participant were encouraged to exercise to their maximum unless they 
experienced clinical signs that required test termination as stated by the ACSM’s 
Guidelines for Exercise Testing and Prescription (3). The mean coefficient of variation 
for assessing peak Vo2 utilizing the Bruce or modified Bruce protocol has been shown to 
be 6.5% (range, 2.0-14%) (44). This test was performed to determine maximal aerobic 
capacity and anaerobic threshold to measure the effects of exercise and diet-induced 
weight loss training on makers of health and fitness on exercise capacity. 
Isotonic strength tests  
Participants in the exercise and diet-induced weight loos program had their 1RM 
determined using an isotonic Olympic bench press (Nebula Fitness, Versailles, OH, 
USA) and a standard hip sled/leg press (Nebula Fitness, Versailles, OH, USA) to 
determine changes in maximal strength according to standardized procedures. Hand 
positioning on the bench press and foot and seat position on the hip sled/leg press were 
standardized between trails. Muscular endurance was assessed by having participants 
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perform as many repetitions as possible at 80% of their predetermined 1RM on the 
bench press and leg press using standard lifting techniques and testing criteria (7).  
All strength/exercise tests were conducted using standard procedures and were 
supervised by certified lab assistants experienced in conducting strength/anaerobic 
exercise testing. We tested for upper body strength and endurance; participants 
performed one repetition maximum (1RM) test on the isotonic bench press and the 
Nebula Fitness (Versailles, OH, USA) Olympic Power Station (#1005). Participants 
performed a warm-up (2 sets of 10 repetitions at approximately 50% of anticipated 
1RM) followed by progressive lifts starting at about 70% of anticipated 1RM and 
increasing by 5–10 lbs. until 1 RM is reached.  Once the 1RM was attained, subjects 
performed as many repetitions as possible with 80% of their 1 RM efforts.  Participants 
rested for 4 minutes, then performed a warm up of 8-10 repetitions at approximately 
50% of anticipated maximum on the Nebula 45° Leg press. Participants performed 
successive lifts on the leg press starting at about 70% of anticipated 1RM and increasing 
by 10–25 lbs. until 1RM was be attained. Once the 1RM was achieved, subjects 
performed as many repetitions as possible with 80% of their 1 RM efforts. Test-retest 
reliability of performing these strength tests on resistance-trained subjects in the ESNL 
have yielded low mean coefficients of variation and high reliability for the bench press 
(1.9%, intraclass r = 0.94) and leg press/hip sled (0.7%, intraclass r = 0.91) (170). 
Blood collection and analysis 
Participants donated approximately 2 teaspoons of fasting venous blood (10 
milliliters). Blood samples were obtained using standard phlebotomy procedures using 
 46 
 
 
standard sterile venipuncture of an antecubital vein by ESNL laboratory technicians or 
graduate research assistance trained in phlebotomy in compliance with guidelines 
established by the Texas Department of Health and Human Services. The phlebotomists 
and lab technicians wore personal protective clothing (gloves, lab coats, etc.) when 
handling blood samples. About 10 ml of whole blood was collected from each 
participant in EDTA tubes. The EDTA tube contains a gel that forms a physical barrier 
between serum and white blood cells (buffy coat) and red blood cells during 
centrifugation. After collection, BD Vacutainer® SST™ Serum Separation Tubes were 
centrifuged immediately after collection at 1,200g for 15min at 4
o
C to spin down the 
blood cells, and the supernatant (serum) were transferred into two 1.5ml microcentrifuge 
tubes, followed by transferring the intermediate white layer or WBC (buffy coat) using a 
plastic 3 ml transfer pipette into appropriately labeled 1.5 ml Eppendorf tubes. Serum 
blood samples were sent to Quest Diagnostics (Houston, TX) for comprehensive 
metabolic panel analysis using an Olympus AAU 5400 Chemistry Immuno Analyzer 
(Olympus America Inc., Center Valley, PA).  Whole blood samples were analyzed for 
complete blood counts with platelet differentials using an Abbott Cell Dyn 3500 
automated hematology analyzer (Abbott Laboratories, Abbott Park, IL).  Reported test to 
test reliability of performing these assays generally range from 2 to 6% for individual 
assays. Samples were run in duplicate to verify results if the observed values were 
outside control values and/or clinical norms according to standard procedures. The 
serum and white blood cells (buffy coat) were then aliquoted and stored at -80C until 
analyzed for the blood lipid panel (Triglyceride, HDL, LDL and total cholesterol), 
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microRNAs (21 and 146a), cytokines expression IL-6 and TNF-α), PTEN, TRAF6, 
PI3K, AKT, NF-kB signaling pathway.  
RNA extraction and real-time PCR analysis of cytokines, mRNAs and microRNAs 
Total RNA was isolated from 200ul serum and white layer according to the 
manufacturer's recommended protocol using the mirVana PARIS kit (Ambion, USA) for 
mRNA analysis and the mirVana
TM
 miRNA isolation kit (Applied Biosystems, Foster 
City, CA) for micro-RNA analysis. Samples were evaluated for nucleic acid quality and 
quantity using the NanoDrop® ND-1000 Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE). Isolated RNAs were synthesized to cDNA using a Reverse 
Transcription Kit (Invitrogen Corp., Grand Island, NY) according to the manufacturer's 
protocol. RT-PCR was carried out with the SYBR Green PCR Master Mix from Applied 
Biosystems (Foster City, CA) on an ABI Prism 7900 HT Sequence Detection System 
(Applied Biosystems Inc, Foster City, CA) with appropriate cycle conditions. Primers 
were designed using Primer Express software (Applied Biosystems, Foster City, CA). 
Each primer was a homology-searched by an NCBI BLAST search to ensure that 
it is specific for the target mRNA transcript. The pairs of forward and reverse primers 
will be purchased from Integrated DNA Technologies, Inc. (San Diego, CA). Product 
specificity was examined by dissociation curve analysis.   Table 7 shows the microRNA 
and mRNA primers used for RT-PCR in the exercise and diet-induced weight loss study 
program for the duration of the study. 
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Table 7. microRNA and mRNA primers used in RT-PCR genes expression analysis 
microRNAs     
microRNA-21 UAGCUUAUCAGACUGAUGUUGA  
microRNA-146a GGGTGAGAACTGAATTCCA  
microRNA-U6B ACG CAA ATT CGT GAA GCG TT  
mRNAs Sense sequence (5' → 3') Antisense sequence (3' → 5') 
PTEN ACCAGGACCAGAGGAAACAT        TTTGTCAGGGTGAGCACAAG 
TRAF6 TGGCATTACGAGAAGCAGTG  GTACCATCTTGTGCAAACAACC 
PI3K GCTTGTTCTGTGGTTGCAGA TAGTGGAGCACCAGCTCCTT 
AKT GGGCCTAGGTGTTGTCATGT                         
AAGAGAGTGTTCGGGGGAAT 
AAGAGAGTGTTCGGGGGAAT 
NF-kB TGGGAATGGTGAGGTCACTCT TCCTGAACTCCAGCACTCTCTTC 
IL-6 AGGGCTCTTCGGCAAATGTA GAAGGAATGCCCATTAACAACAA 
TNF-α CCCAGGCAGTCAGATCATCTTC AGCTGCCCCTCAGCTTGA 
GAPDH CCATCCCAGACCACCTAAC GCAGCGAACTTTATTGATGA 
 
Quantification of microR-NU6B, microR-146a, and microR-21 were performed 
using the Taqman® MicroRNA reverse transcription kit (Applied Biosystems, Foster 
City, CA). For the PCR reaction, the reverse transcription product will be diluted as 1:15 
and amplified using TapMan® 2× Universal PCR Master Mix (No AmpErase® UNG) 
(Applied Biosystems, Foster City, CA) according to the manufacturer's specifications. 
The expression levels of the microRNAs were determined using 2
-∆∆Ct
 and normalized to 
microR NU6B small nuclear RNA. The expression level of mRNA was determined 
using 2
-∆∆Ct
 and normalized to GADPH for mRNAs (IL-6, TNF-α, PTEN, TRAF6, AKT, 
PI3K and NF-kB) expressions.  
Luminex inflammatory cytokine analysis 
The Luminex® assay was performed using the Multiplex L200 (Austin, TX) with 
the high sensitive human inflammatory marker kit (Millipore, Billerica, MA) following 
the manufacturer's protocol. Data were analyzed using Luminex xPonent 3.0 software 
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(Millipore, Billerica, MA). This quantitative measure is considered a kinetic enzymatic 
method to measure gene expression in serum and white blood cells. The analyses of 
these blood parameters were performed to determine the exercise and diet-induced 
weight loss intervention on markers of clinical health, inflammatory cytokines gene 
expression and microRNAs expression. 
Statistical analysis 
Related data were analyzed by Multivariate Analysis of Variance (MANOVA) 
with repeated measures (PASW Statistics version 20, 2011, SPSS Inc, Chicago, IL.).  
Overall MANOVA effects were examined using Wilks’ Lamda time and group x time p-
levels as well as MANOVA univariate ANOVA group effects. Greenhouse-Geisser 
univariate tests of within of within-subjects time and group x time effects and between-
subjects univariate group effects were reported for each variable analyzed within the 
MANOVA model. In some instances, repeated measures ANOVA was run on variables 
not included in a MANOVA design with univariate group, time, and group x time 
interaction effects reported. Variables with baseline differences determined by ANOVA 
were analyzed using analysis of covariance (ANCOVA).  
Delta values or percent difference were calculated and analyzed on select 
variables by ANOVA for repeated measures to assess changes from baseline values.  
Delta values were calculated by subtracting the first testing session (T1) from later 
testing sessions (T4-T1). Percent differences were calculated by subtracting T1 from the 
later testing session, then performing division by T1 followed by multiplication by 100 
[(T4-T1)/T1·100]. Data were considered statistically significant when the probability of 
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type I error was 0.05 or less and statistical trends were considered when the probability 
error ranged between p > 0.05 to p < 0.10. If a significant group, treatment and/or 
interaction alpha level was observed, Tukey’s least significant difference (LSD) post hoc 
analyses were performed to determine where significance was obtained. Power analysis 
of previous studies using similar designs and subject populations indicated that a sample 
size of 30 subjects per group yielded high power (>0.8) for delta values of 0.75 to 1.25 
for weight and fat loss. All data are presented as means ± standard deviation for baseline 
to 12 wk data analyses and as means ±standard error of the mean for group data 
analyses.  Pearson product correlations were performed to examine relationship of 
changes in body composition to markers of inflammation. 
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CHAPTER IV 
RESULTS 
Participants 
Figure 1 presents a Consort Diagram for participant recruitment, entry, and 
completion observed in this portion of the study. Eighty-two (82) out of 125 subjects 
who called to participate in our 12 wk study program met phone interview entrance 
criteria and were invited to attend familiarizations sessions. All 82 women showed up 
for familiarization sessions and met entrance criteria to participate in the study after 
evaluation of medical history and obtaining consent. All 82 obese women (BMI 
35.6±5.6 kg/m
2
) completed baseline testing and were cleared to participate in the study. 
Of these women, 49 women completed the 12 week study. The primary reasons 
participants dropped out of the study were due to time constraints, work, moving, falling 
sick, Complaints about the exercise program (that it was too intense) and did not want to 
participate in the control group once they found out they were in the control group.  
Table 8 presents the participant demographics data. Forty-nine obese women 
(age 48.2±10.5 years, height 63.5±2.7 cm; weight 203.3±30.5 kg; BMI 35.6±5.6 kg/m
2
; 
45.9±4.4 % body fat) completed the 12-week study (EX group n=29; C group n=20) 
with greater than 80% compliance. One-way ANOVA of baseline demographic data 
revealed no significant differences were observed between groups in baseline age, 
height, weight, BMI, or percent body fat.   
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Table 8.  Baseline demographics for the exercise and diet-induced weight loss (EX) 
and control (C) groups  
                                     Exercise Group       Control Group            
                                           (N=29)                  (N=20)                             P-value 
Age (years) 
 
46.5±10.1 50.6±10.9  0.191 
Height (cm) 
 
63.6±2.6 63.4±3.0  0.874 
Weight (kg) 
 
199.4±30.0 209.0±31  0.288 
BMI
a
 (kg/m²) 
 
34.9±5.9 36.6±5.2  0.307 
DEXA
b 
BF (%) 45.6±3.7 46.3±5.2  0.571 
 
 
All data is presented as means ± SD at baseline. 
aBody mass Index 
 bDual Energy X-ray Absorptiometry 
 
 
 
 
Withdrawal after 
Commencement 
(n=6) Primary 
reasons; were 
time constraints 
and didn’t like 
participating in 
control group. 
Randomization (n=82) 
Allocated to EX 
Group (n=56) 
Allocated to 
C Group 
(n=26) 
Completed 
Study (n=29) 
 
Completed 
Study (n=20) 
Withdrawal after 
Commencement 
(n=27) Primary 
reasons for drop 
out were time 
constraints, work, 
Moving, sick, 
complaints about 
the exercise 
program 
 
Figure 1: Consort diagram for participation.   
Withdrawal Prior 
to 
Commencement 
(N=0) Failed to 
Complete 
Baseline Testing 
 
Eligible for participation 
(N=82) 
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Results 
Energy intake 
Table 9 presents changes in nutritional intake at baseline and 12 weeks of 
program intervention. The completed food records were obtained on all participants 
completing the study.  MANOVA’s were run on energy intake and macronutrient intake 
expressed in kcals/kg/day, g/kg/day, and percentage of total calories consumed. 
MANOVA analysis revealed significant time (Wilks’ Lamda p=0.001), overall group 
(Wilks’ Lamda p=0.001), and an overall time by diet interaction (Wilks’ Lamda 
p=0.003) effects.  MANOVA analysis of percent dietary intake data revealed an overall 
time (Wilks’ Lamda p=0.000), and an overall time by diet interaction (Wilks’ Lamda 
p=0.000).   
MANOVA univariate analysis revealed that the Ex group had a greater reduction 
in energy intake per kilogram body weight than the C group (EX 1,748±515, 1,351±228, 
1,397±311, 1,445±430; C 2,153±725, 1,715±502, 1,783±599, 1,778±555g/kg/d) with a 
significant time (p=0.001) and group (p=0.001) effect observed. Carbohydrate intake 
decreased overtime with a greater reduction in the EX group than in the C group (EX 
187±80.0 129.8±33.5, 127.6±38.6, 124±50.9; C 227±92.8, 188.2±46.5, 187.9±62.1, 
190±71.9) with a significant time (p=0.001) and group (p=0.000) effect observed. 
Univariate analysis revealed a significant time by diet effect (p=0.01) with no significant 
time or group effect. Fat intake resulted in a significant (EX 74.3±29.9, 50.2±18.85, 
53.6±19.2, 58.5±23.77; C 82.5±33.8, 69.4±26.20, 71.8±28.3, 73.9±26.54) time (p=0.01)  
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Table 9. Nutritional intake changes obtained at baseline, 4, 8 and 12 weeks of the program 
participation for the exercise/diet-induce weight loss (EX) and control (C) groups
a
   
Variable Group Baseline  4-weeks 8-weeks 12-weeks Group SEM P values 
Energy 
Intake  
(kcals/kg/d) 
Exercise 
Control 
Total 
1,748±515  
2,153±725 
1,930±643 
1,351±228g 
1,715±502 
1,515±414 
1,397±311 g 
1783±599 
1571±496 
1,445±430g 
1,778±555 
1,594±512 
1,485±71.03g 
1,848±76.43 
Gc = 0.001 
Td = 0.00 
Ie = 0.97 
CHO 
Intake 
(g/kg/d) 
Exercise 
Control 
Total 
187±80.0 
227±92.8 
205±87.3 
129.8±33.5g 
188.2±46.5 
156.1±49.1 
127.6±38.6g 
187.9±62.1 
154.7±58.3 
124±50.9g 
190±71.9 
154±69.1g 
141.9±8.30g 
196.9±8.93 
Ggh = 0.00 
Tgh = 0.001 
 I = 0.59 
Protein 
Intakef  
(g/kg/d) 
Exercise 
Control 
Total 
74.5±17.7 
86.3±30.3 
79.8±24.6 
83.1±26.36 
68.6±20.46 
76.6±24.70 
84.7±18.47 
69.3±28.01 
77.8±24.21 
83.8±22.27 
74.5±22.06g 
79.6±22.39 
81.5±3.32 
74.3±3.58 
G = 0.15 
T = 0.61 
 Ig= 0.01 
Fat Intake  
(g/kg/d) 
Exercise 
Control 
Total 
74.3±29.9 
82.5±33.8 
78.0±31.6 
50.2±18.85 
69.4±26.20 
58.8±24.18 
53.6±19.2 
71.8±28.3 
61.8±25.1 
58.5±23.77 
73.9±26.54 
65.5±25.91g 
59.1±3.84g 
74.2±4.13 
G g= 0.01 
Th = 0.002 
 I= 0.57 
CHO 
Intake  
(%) 
Exercise 
Control 
Total 
42.4±9.12 
43.6±5.17 
42.9±7.54 
40.0±8.93 
45.8±4.89 
42.6±7.87 
37.9±7.00 
44.5±6.31 
40.8±7.40 
35.6±8.05 
43.6±7.36 
39.2±8.66 
39.0±1.00g 
44.4±1.12 
Ggh = 0.001 
T = 0.08 
 I = 0.13 
Protein 
Intake  
(%) 
Exercise 
Control 
Total 
18.4±5.09 
17.2±4.07 
17.8±4.64 
25.5±7.00 
16.7±3.55g 
21.6±7.19g 
26.1±6.09 
16.5±3.33g 
21.8±6.95g 
25.3±6.69 
17.7±3.82g 
21.9±6.73g 
23.8±0.82g 
17.0±0.91 
G gh= 0.00 
Tgh =0.001 
 Igh= 0.00 
Fat Intake 
(%) 
Exercise 
Control 
Total 
38.4±7.31 
37.1±6.13 
37.7±6.75 
34.0±9.69 
36.6±4.96 
35.2±7.94 
35.4±7.21 
36.0±5.51 
35.7±6.43 
37.7±7.42 
38.1±5.18 
37.9±6.44 
36.3±1.07 
36.9±1.18 
G = 0.71 
T = 0.09 
 I = 0.47 
aComplete food intake records were obtained at Baseline and 12 weeks for 29 participants in the group  EX and 20 
participants in the group C (N=49).  Data were analyzed using ESHA Food Processor Nutritional Analysis Software 
(Version 8.6).    
bp<0.05 difference from baseline. 
cG=group alpha level. 
dT=time alpha level. 
eI=group x time interaction alpha level. 
fProtein intake 
Group SEM=group standard error of the mean 
gp<0.01 difference between EX and C groups. 
hp<0.05 difference between EX and C groups. 
 
and group (p=0.002) effect observed. Our results also revealed a significant increase 
percent protein intake in the EX group compared to the C group (EX 18.4±5.09, 
25.5±7.00, 26.1±6.09, 25.3±6.69; C 17.2±4.07, 16.7±3.55, 16.5±3.33, 17.7±3.82 with a 
significant time (p=0.001) and group (p=0.000) and time by diet (p=0.000) effect 
observed. Percent carbohydrate intake revealed an increased effect in the Ex group 
compared to the C group (EX 42.4±9.12, 40.0±8.93, 37.9±7.00, 35.6±8.05; C 43.6±5.17, 
45.8±4.89, 44.5±6.31, 43.6±7.36) with a significant group (p=0.001) effect and no 
significant time (p=0.08) effect observed. There was no significant effect observed with 
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percent fat intake. These findings indicate that protein intake was greater in the exercise 
and diet intervention group. 
Body composition  
 Table 10 presents changes in body composition observed during the study. 
MANOVA analysis of body composition data revealed overall time (Wilks’ Lamda 
p=0.000) and time by diet effects (Wilks’ Lamda p=0.000). Univariate analysis revealed 
significant time effects for body weight (p=0.001), fat mass (p=<0.001), and percent 
body fat (p=0.001).  
 
Table 10. Changes in body composition and fitness related data values observed at baseline, 
4, 8 and 12 weeks of program participation for the exercise/diet-induced weight loss (EX) 
and control (C) groups
a
   
Variable Group Baseline 4-weeks 8-weeks 12-weeks Group SEM p-value 
Total 
Mass 
(kg) 
Exercise 
Control 
Total 
84.18±13.05 
88.44±13.58 
85.92±13.30 
82.17±13.51 
88.31±12.88 
84.68±13.47 
81.04±13.4b 
88.50±12.85 
84.08±13.57 
80.18±13.51b 
88.55±12.82 
83.60±13.74b 
 
81.90±2.44 
88.45±2.94 
Gcb =0.09 
Tdb=0.001 
Ieb= 0.00 
Fat Mass  
(kg)  
Exercise 
Control 
Total 
38.59±7.97 
41.12±9.15 
39.62±8.47 
36.58±8.74 
41.08±8.18 
38.42±8.72 
35.21±8.40b 
41.26±7.98 
38.68±8.69 
34.78±8.87b 
41.09±8.33 
37.36±9.12b 
36.29±1.56b 
41.14±1.87 
Gb = 0.05 
Tb =0.00 
Ib = 0.00 
Fat-free 
Mass  
(kg)  
Exercise 
Control 
Total 
45.60±6.47 
47.32±7.72 
46.29±6.99 
 
45.60±6.35 
47.22±7.30 
46.26±6.73 
45.83±6.83 
47.21±7.46 
46.40±7.05 
45.40±6.34 
47.46±7.22 
46.24±6.72 
45.60±1.26 
47.31±1.52 
G =0.39 
T = 0.96 
I = 0.58 
Body Fat  
(%) 
Exercise 
Control 
Total 
45.60±3.73 
46.33±5.24 
45.90±4.37 
44.10±4.69 
46.42±4.51 
45.05±4.71 
43.07±4.94b 
46.60±4.54 
44.51±4.05 
42.85±5.38b 
46.27±4.52 
44.25±5.28b 
43.91±0.84 
46.41±1.02 
Gb = 0.07 
Tb= 0.00 
Ib= 0.00 
aData are from 29 participants in the EX group and 20 participants in the C group (n=49) who completed the 12-week 
study.   
bp<0.05 difference from baseline. 
cG=group alpha level. 
dT=time alpha level. 
eI=group x time interaction alpha level. 
Group SEM=group standard error of the mean 
 
 
 
Participants in the EX group experienced greater changes in body weight (EX -4.0±4.4 
kg; C 0.1±3.0 kg, p=0.001), fat mass (EX -3.8±4.0 kg; C -0.03±2.0 kg, p<0.001), and 
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percent body fat (EX -2.7±3.4%; C -0.1±1.7%, p=0.002). No differences among groups 
were observed in FFM (EX -0.2±2.0 kg; C 0.1±2.3 kg, p=0.59). Review of body 
composition data lead to acceptance hypothesis H1 that the exercise and diet intervention 
would promote statistically significant differences in body composition measures 
compared to controls and thus, based on our results data we therefore accepted our H1 
hypothesis. Figure 2 represents changes from baseline to 12-wk between our exercise 
and diet-induced weight loss and control group on body composition. 
 
                 
Figure 2. Data are presented as means ±SD of body composition. *P <0.05 significant differences from 
baseline to 12-wk between the exercise and diet-induced weight loss and control groups. 
 
 
Fitness assessment 
Table 11 presents changes in markers of fitness observed during the study.  
MANOVA analysis revealed a significant time effect (p<0.001) and group x time effect 
(p=0.002) for measures of fitness. Univariate analysis revealed significant VO2max 
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(p=0.014) and lower body 1-RM (p<0.001). Participants in the EX group experienced 
greater changes in VO2max (EX 13.6±17.0%; C -2.2±10.3%, p=0.001) and upper body 
(EX 8.7±12.5%; C -1.2±13.9%, p=0.016) 1-RM while no differences in lower body 1-
RM strength were observed between groups (EX 15.0±21.9%; C 13.8±23.7%, p=0.86) 
after 12 weeks of program participation. 
 
Table 11.  Changes in general health and fitness values obtained at baseline and 12 weeks of 
program participation for the exercise/diet-induced weight loss (EX) and control (C) groups
a
  
Variable Group Baseline 12 -weeks Group SEM p-value 
Peak VO2
g  
(L/min) 
Exercise 
Control 
Total 
1.84±0.2 
1.77±0.3 
1.81±0.3 
 
1.94±0.2b 
1.72±0.3 
1.86±0.3 
 
1.89±0.05b 
1.74±0.06 
Gb = 0.05 
T = 0.19 
Ijb = 0.004 
Peak VO2
g  
(ml/kg/min) 
Exercise 
Control 
Total 
20.5±3.1 
18.7±3.1 
19.8±3.2 
 
23.1±3.4jb 
18.2±3.3 
21.1±4.1jb 
 
21.77±0.57jb 
18.49±0.71 
Gjb = 0.001 
Tj = 0.008 
Ijb = 0.00 
Treadmill Time 
(min) 
Exercise 
Control 
Total 
7.6 ±0.9 
6.7±1.4 
7.2±1.2 
 
8.4±0.8b 
6.8±1.4 
7.8±1.3bj 
 
8.02±0.19bj 
6.73±0.25 
Gjb=0.00 
Tjb=0.00 
Ib=0.004 
Bench Press  
1 RMh (kg) 
Exercise 
Control 
Total 
67.89±13.58 
70.56±19.55 
68.97±16.12 
 
73.27±14.28j 
69.44±20.78 
71.70±17.12 
 
70.58±3.18 
70.00±3.83 
G = 0.91 
T = 0.09 
Ij = 0.01 
Bench Lifting 
Volumek      
(repetitions*kg) 
Exercise 
Control 
Total 
204.08±91.14 
160.49±115.94 
186.25±103.02 
 
205.83±116.69 
152.28±55.04 
183.92±99.12 
 
204.95±17.47 
156.39±20.99 
G = 0.08 
T = 0.81 
I = 0.71 
Leg Press 1 RM (kg)  Exercise 
Control 
Total 
366.92±113.68 
392.78±145.39 
377.50±126.64 
 
420.77±153.57 
437.50±171.41 
427.61±159.37j 
 
393.85±27.14 
415.14±32.61 
G = 0.62 
Tjb = 0.001 
I = 0.74 
Leg Lifting Volumek       
(repetitions*kg) 
Exercise 
Control 
Total 
1,931±1,531 
1,838±758 
1,893±1,262 
 
2,595±2,624 
1,850±760 
2,290±2,090 
 
2,263±297.81 
1,844±357.92 
G = 0.37 
T = 0.19 
I = 0.20 
aData are from 29 participants in the EX group and 20 participants in the C group (n=49) who completed the 12-week study.   
bp<0.05 difference from baseline. 
cG=group alpha level 
dT=time alpha level 
eI=group x time interaction alpha level 
gPeak VO2 = peak oxygen uptake. 
h1 RM = 1 repetition maximum 
iBench press lifting volume at 80% 1 RM (kg) 
jp<0.01 difference between EX and C groups. 
kLeg Press lifting volume at 80% 1 RM (kg) 
Group SEM=group standard error of the mean 
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Consideration of peak V02, fitness and upper extremity muscular strength data 
led to acceptance of H2 that the exercise and diet intervention would promote statistically 
significant differences in marker of health and fitness compared to controls. The graph in 
Figure 3 below illustrates changes from baseline to 12-wk between our exercise and diet-
induced weight loss and control groups in measures of fitness assesses during our 12-wk 
program. 
 
            
Figure 3. Data are presented as means ±SD of markers of fitness. *P<0.05 significant differences from 
baseline to 12-wk between the exercise and diet-induced weight loss and control groups. 
 
 
 
Biochemical markers of health 
Table 12 presents changes in fasting blood lipid and blood glucose values 
observed at Baseline, 4, 8 and 12 weeks of program participation.  Overall MANOVA 
analysis revealed a non-significant time effect (Wilks’ Lambda p=0.23) and a very 
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significant group x time effect (Wilks’ Lambda p=0.04) for blood lipid markers. 
Univariate analysis revealed significant time effects for low-density lipoprotein 
cholesterol (p=0.037). No differences for participants in the EX group were observed for 
triglycerides (EX -6.7±26.4%; C 0.1±24.4%, p=0.37), total cholesterol (EX -3.6±10.0%; 
C -2.2±10.7%, p=0.65), high density lipoprotein cholesterol (EX 2.5±15.1%; C -
5.0±10.5%, p=0.06); low-density lipoprotein cholesterol (EX -4.7±11.5%; C -
4.0±16.8%, p=0.87) or blood glucose (EX -0.6±14.5%; C -1.3±8.4%, p=0.847). 
 
Table 12.  Fasting blood lipid and blood glucose values obtained at baseline, 4, 8 and 12 
weeks of program participation for the exercise and diet-induced weight loss (EX) and 
control (C) groups
a
 
Variable Group Baseline 4-weeks 8-weeks 12-weeks Group SEM p-value 
Total 
Cholesterol  
(mg/dl)b 
Exercise 
Control 
Total 
191.3±30.7 
192.9±33.0 
192.0±31.4 
178.7±27.9 
192.4±32.4 
184.4±30.3 
183.1±32.9 
190.5±31.8 
186.2±32.3 
184.2±33.0 
188.2±35.6 
185.8±33.8 
184.3±5.6 
191.0±6.7 
 
G= 0.45 
T=0.08 
I= 0.16 
HDLc  
(mg/dl) 
 
Exercise 
Control 
Total 
54.7±13.2 
51.4±10.5 
53.3±12.1 
52.4±11.5 
51.7±11.9 
52.1±11.5 
54.7±15.6 
49.5±105 
52.6±13.8 
55.82±14.2 
49.20±12.1 
53.0±13.7 
54.4±2.3 
50.4±2.7 
G = 0.27 
T = 0.68 
I = 0.15 
LDLc (mg/dl) 
 
Exercise 
Control 
Total 
111.1±22.7 
122.3±50.6 
115.7±36.9 
101.7±21.8 
114.9±32.6 
107.2±27.3 
103.1±25.2 
116.5±26.6 
108.7±26.4 
105.3±22.6 
112.4±30.6 
108.2±26.2 
 
105.3±5.0 
116.5±5.9 
G = 0.66 
Tc=0 .04 
I= 0.59 
Triglyceridesh 
(mg/dl) 
 
Exercise 
Control 
Total 
127.8±64.6 
139.8±58.4 
132.8±61.7 
122.8±60.7 
128.0±43.1 
125.0±53.6 
118.3±68.1 
112.4±40.1 
120.0±57.6 
114.9±58.7 
133.2±43.9 
122.5±53.3 
121.0±9.9 
130.8±11.7 
G = 0.52 
T = 0.09 
I= 0.50 
Blood glucose 
(mg/dl) 
 
 
Exercise 
Control 
Total  
93.5±16.1 
96.9±9.9 
94.9±13.8 
94.0±16.7 
98.5±12.5 
95.8±15.1 
94.2±14.1 
99.1±9.1 
96.2±12.4 
91.5±11.1 
93.3±10.5 
93.1±10.9 
93.1±2.0 
97.4±2.4 
G = 0.18 
T = 0.24 
I= 0.96 
 
 
aLipid and glucose data were obtained at 0, 4, 8 and 12 weeks on 29 participants in the EX group and 20 participants 
in the C group (n=49) completing the 12week weight loss program.  
bTo convert mg/dL cholesterol to mmol/L, multiply mg/dL by 0.026.  To convert mmol/L cholesterol to mg/dL, 
multiply mmol/L by 38.6.  Cholesterol of 194 mg/dl=5.04 mmol/L. 
cp<0.05 difference from baseline and between EX and C groups 
G=group alpha level. 
eT=time alpha level. 
I=group x time interaction alpha level. 
Group SEM=group standard error of the mean 
hTo convert mg/dL triglyceride to mmol/L, multiply mg/dL by 0.0113.  To convert mmol/L triglyceride to mg/dL, 
multiply mmol/L by 88.6.  Triglyceride of 137 mg/dl=1.55 mmol/L. 
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Results indicate that participation in a structured exercise and diet-induced 
weight loss program promotes effective weight loss and improvement in some markers 
of health in support of H2.   Figure 4 illustrates changes from baseline to 12-wk between 
our exercise and diet-induced weight loss and control groups in changes in markers of 
health assesses during our 12-wk program. We observed a significant difference from 
baseline to 12-wk with triglycerides. 
 
      
Figure 4. Data are presented as means ±SD of markers of health. *P<0.05 significant differences from 
baseline to 12-wk between the exercise and diet-induced weight loss and control groups with triglycerides. 
 
 
 
Biochemical markers of inflammation and gene expression 
Table 13 represents changes in overweight women (48.16±10.5 yr, 45.9±4.4% 
body fat, BMI 35.6±5.6 kg/m
2
) in microRNAs (21 and 146a) and mRNAs of IL-6, TNF-
α, (PTEN, TRAF6)/PI3k/AKT/NF-kB genes expression analysis values observed at 
Baseline and 12 weeks of program participation. MANOVA analysis of genes 
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expression data revealed a significant overall time (Wilks’ Lamda p=0.000), group effect 
(Wilks’ Lambda p=0.000) and time by group effects (Wilks’ Lamda 
p=0.000).  MANOVA univariate analysis revealed no significant interactions among 
groups in changes in microRNA 146a (EX -0.73±2.0; C -0.28±2.1, p=0.46); TRAF6 (EX 
–1.35±2.7; C -0.74±3.5, p=0.52); mRNA expression levels of PI3K (EX -2.4±4.5; C -
1.8±2.9, p=0.66); AKT (EX -1.34±4.2; C -0.67±7.4, p=0.70); or, mRNA NF-kB (EX -
1.6±3.2; C -0.73±3.2, p=0.40). Significant interactions were observed among groups in 
changes in microRNA 21 (EX -1.5±2.34; C 0.13±2.2, p=0.03); mRNA expression level 
of its target gene PTEN (EX -4.5±3.2; C -1.6±3.4, p=0.005); mRNA IL-6 (EX -2.8±3.6; 
C 2.8±2.2, p=0.000); and, mRNA TNF-α expression levels (EX -0.52±2.5; C 2.3±1.9, 
p=0.000). Decreased microRNA (21 and 146a) were positively and significantly 
correlated to body weight, total weight, fat mass and body fat percent with circulatory 
levels of IL-6 and TNF-α.  
Review of our H01 hypothesis initially state that the exercise and diet intervention 
will not result in a statistically significant differences in mRNA TNF-α expression 
compared to controls. Based on our TNF-α (P<0.000) data observed, we therefore reject 
our H01. We accepted partially accept our Ho2 because microRNA-21 (p<0.03) was 
significantly different from baseline and microRNA-146a (p<0.46) was not. We had 
previously hypothesized that there will be no statistically significant differences between 
groups in changes in mRNA PTEN. We found based on our results that mRNA PTEN 
was statistically significant (p< 0.005). Therefore, we reject our H03. Also we have 
previously hypothesized that there will be no statistically significant differences between 
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groups in changes in mRNA TRAF6. We found based on our results that mRNA TRAF6 
was not statistically significant (p< 0.52). Therefore, we accept our H04.  At the beginning 
of our study we hypothesized that there will be no statistically significant differences 
between groups in changes in mRNA PI3K. 
 
Table 13. Changes in microRNAs and mRNAs values obtained at baseline and 12 
weeks of program participation for the exercise/diet-induced weight loss (EX) and 
control (C) groups
a
.  
 
Variable 
 
Group 
 
Baseline 
 
 
12-weeks 
 
 
 
Group SEM 
 
p-value 
 
microRNA21/micro 
RNAU6B (AU) 
Exercise 
Control 
Total 
5.30±2.56b 
2.43±1.87 
4.15±2.69 
3.84±1.45b 
2.56±1.27 
3.33±1.51 
4.57±0.29b 
2.49±0.36 
Gc = 0.00 
Td=0.06 
Ie= 0.03 
microRNA146a/micro
RNAU6B (AU) 
Exercise 
Control 
Total 
4.53±2.41 
3.52±1.27 
4.13±2.07 
3.79±1.65 
3.23±1.22 
3.57±1.51 
4.17±0.29 
3.38±0.35 
G = 0.08 
T= 0.10 
I=0.46 
PTEN /GAPDH(AU) Exercise 
Control 
Total 
7.79±3.10 
8.68±2.02 
8.15±2.73 
3.27±1.54b 
7.09±2.88 
4.80±2.86b 
5.53±0.36b 
7.89±0.44 
Gb = 0.00 
Tb = 0.00 
Ib= 0.005 
TRAF6 /GAPDH 
(AU) 
 
Exercise 
Control 
Total 
8.45±2.63b 
10.64±2.60 
9.32±2.81 
7.09±2.72b 
9.89±2.46 
8.22±2.94b 
7.77±0.41b 
10.27±0.50 
Gb = 0.00 
Tb = 0.03 
I = 0.52 
PI3K/ GAPDH (AU) 
 
Exercise 
Control 
Total 
11.23±3.16b 
9.21±2.85 
10.42±3.17 
8.84±3.13 
7.37±1.78 
8.26±2.75b 
10.04±0.39b 
8.29±0.49 
Gb = 0.008 
Tb = 0.001 
I = 0.66 
(AKT/PKB)/GAPDH 
(AU) 
Exercise 
Control 
Total 
13.45±2.04 
15.30±4.87 
14.19±3.53 
12.10±3.76 
14.63±6.29 
13.11±5.03 
12.77±0.61 
14.97±0.74 
Gb=0.028 
T=0.25 
I=0.69 
NF-kB /GAPDH (AU) 
 
Exercise 
Control 
Total 
9.56±2.83b 
6.31±2.81 
8.26±3.22 
7.98±2.66b 
5.57±2.33 
7.02±2.78b 
8.77±0.41b 
5.94±0.51 
Gb = 0.00 
Tb = 0.023 
I =0.40  
IL-6 /GAPDH (AU)  Exercise 
Control 
Total 
7.18±2.87b 
3.42±1.59 
5.68±3.05 
4.40±2.43b 
6.22±2.75 
5.13±2.69 
5.79±0.37 
4.82±0.46 
G = 0.11 
T = 0.98 
I b= 0.00 
TNF-α/GAPDH (AU) Exercise 
Control 
Total 
7.40±2.05 
5.01±1.90 
6.44±2.30 
6.88±2.05b 
7.29±0.82 
7.04±1.67b 
7.14±0.28b 
6.15±0.34 
G b= 0.03 
Tb = 0.02 
Ib = 0.00 
aData are from 29 participants in the EX group and 20 participants in the C group (N=49) who completed the 12-
week study.   
bp<0.05 difference from baseline and between EX and C groups 
Group SEM=group standard error of the mean 
cG=group alpha level 
dT=time alpha level 
eI=group x time interaction alpha level 
AU= arbitrary units 
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We found based on our results that mRNA PI3K was not statistically significant 
(p<0.66). This led us to acceptance of our H05. We again hypothesized earlier that there 
will be no statistically significant differences between groups in changes in mRNA 
AKT. We also found based on our results that mRNA AKT was not statistically 
significant (p< 0.70). We therefore accept H06. We initially that, there will be no 
statistically significant differences between groups in changes in mRNA NF-kB. We 
found based on our results that mRNA NF-kB was not statistically significant (p< 0.40). 
Therefore, we accept our H07.   
Based on our results data, review of mRNAs of IL-6 and TNF-a genes expression 
analysis data resulted in acceptance of H3 (p<0.000). We have previously stated that the 
exercise and diet intervention will promote a statistically significant difference in mRNA 
IL-6 (H3) and mRNA TNF-α (H4). Also based on our result data we therefore accept of 
H4 (p<0.000) and reject our H01 in which we stated that the exercise and diet intervention 
will not result in statistically significant differences in mRNA TNF-α expression 
compared to control. Figures 5a and 5b presents changes from baseline to 12-wk 
between our exercise and diet-induced weight loss and control group on markers of 
inflammation. 
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Figure 5a. Data are presented as means ±SD of markers of inflammation from baseline to 12-wk between 
the exercise and diet-induced weight loss and control groups. 
 
 
           
 
Figure 5b. Data are presented as means ±SD of markers of inflammation and microRNA 21. 
*P<0.05 significant differences from baseline to 12-wk between the exercise and diet-induced weight loss 
and control groups. 
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CHAPTER V 
DISCUSSION AND CONCLUSION 
Obesity has been on the rise for decades especially with increasing rise in fast 
food restaurants, food processing industries, over nutrition and most of all the high rate 
of physical inactivity around the world. Obesity has been associated with increases in 
markers of inflammation (144). Intense exercise increases markers of inflammation (68, 
122).  However, chronic exercise and diet-induced weight loss has been suggested to 
decrease makers of inflammation in obese populations (124, 154, 155, 157). Additional 
research is needed to examine gene expression and molecular changes related to weight 
loss.   
Our investigation looked at the effects of exercise and diet-induced weight loss in 
overweight/obese women on the characterization of serum/plasma microRNAs and 
cytokine gene transcription on body composition and markers of health and fitness. We 
also looked at microRNA-21, microRNA-146a and the mRNAs of IL-6, TNF-α, (PTEN, 
TRAF6)/PI3k/AKT/NF-kB genes expression analysis in previously sedentary obese 
women. Some studies have investigated the efficacy of exercise and diet-induced weight 
loss on markers of fitness and inflammation but not connected to microRNAs and their 
regulatory role with respect to exercise and diet-induced weight loss.  
  In this study, forty-nine obese women were assigned to an exercise and diet 
group or a non-exercise and non-diet control group.  No significant differences were 
observed between groups in baseline age, height, weight, BMI, or percent body fat as 
determined by ANOVA. Results revealed that participants in the exercise and diet 
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intervention group experienced significant reductions in body weight and fat mass with 
no changes observed in FFM in comparison to controls. Participants also improved their 
fitness, some markers of health, and experienced a significant reduction in some markers 
of inflammation. These finding support previous research that has shown that exercise 
and/or diet induced weight loss can reduce markers of inflammation in obese 
individuals. 
While these findings are not novel, our investigation extended previous research 
by examining the effects of exercise and diet-induced weight loss on microRNAs (21 
and 146a) and mRNAs of IL-6, TNF-α, (PTEN, TRAF6)/PI3k/AKT/NF-kB genes 
expression (see Figure 6).  We found that exercise and diet-induced weight loss resulted 
in an overall effect on these markers with more influence on some markers than others. 
More specifically, we found no significant interaction effects among groups in changes 
in pathway #2 microRNA 146a (EX -0.73±2.0; C -0.28±2.1, p=0.46); TRAF6 (EX –
1.35±2.7; C -0.74±3.5, p=0.52); mRNA expression levels of PI3K (EX -2.4±4.5; C -
1.8±2.9, p=0.66); AKT (EX -1.34±4.2; C -0.67±7.4, p=0.70); or, mRNA NF-kB (EX -
1.6±3.2; C -0.73±3.2, p=0.40).  However, significant interactions were observed among 
groups in changes in pathway #1 microRNA 21 (EX -1.5±2.34; C 0.13±2.2, p=0.03); 
mRNA expression level of its target gene PTEN (EX -4.5±3.2; C -1.6±3.4, p=0.005); 
mRNA IL-6 (EX -2.8±3.6; C 2.8±2.2, p=0.000); and, mRNA TNF-α expression levels 
(EX -0.52±2.5; C 2.3±1.9, p=0.000). Decreased microRNA (21 and 146a) were 
positively and significantly correlated to body weight, total weight, fat mass and body fat 
percent with circulatory levels of IL-6 and TNF-α (175). Many investigations looking at 
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the effects of exercise on gene expression in human peripheral blood mononuclear cells, 
on microRNAs observed significant effects demonstrating the relationships between NF-
kB and how this transcription factor regulates many genes involved in inflammation (8, 
27, 90, 133, 138, 146, 151, 153, 168).    
 
 
 
Figure 6: The diagram represents significant reductions and changes from baseline after 12 weeks. 
Figure illustrates gene levels from blood samples collected from 49 obese women (BMI 35.6±5.6 kg/m
2
; 
45.9±4.4 % body fat) analyzed using real time-PCR.  * P < 0.05 significant effect of the exercise and diet-
induced weight loss intervention.  
 
 
 
Our main finding showed that microRNA-21, PTEN, IL-6 and TNF-α decreased 
significantly during our exercise and diet-induced weight loss program. Our study 
* 
* 
* 
Pathway #1 Pathway #2 
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showed that IL-6 and TNF-α were significantly reduced through our exercise program 
on obese women with BMI 35.6±5.6 kg/m
2
. In a study conducted by Nicklas et al (102) 
looking at the effects of exercise training (lower body resistance training with weighted 
cuff 3 times/wk and walking at 50 to 70% heart rate reserve for 18 months)  in obese 
individuals on IL-6 and TNF-α levels, showed that IL-6 and TNF-α decreased significant 
by 11% and 2% respectively. Their results agrees to our results obtained during our 
exercise and diet-induced weight loss study in which we showed that IL-6 and TNF-a 
decreased significant during our 12 wk study program. Another study conducted by 
Tsukui et al (160) confirm our results obtained on IL-6 and TNF-α. They conducted a 5 
month training intervention program, 30-45 min/d/wk, 4-5 d/wk at 40-50% VO2max. 
Their result demonstrated that their exercise program intervention significantly decreases 
body weight, percent body and TNF-α from 9.0 to 1.5 pg/ml. Interestingly, a study 
conducted by Lambert et al (84) evaluated the effect of exercise (12 wk aerobic 30-40 
min and resistance 30-40 min, 3 d/wk at 75% peak heart rate) but not diet-induced 
weight loss decreases inflammation gene expression in frail obese persons. They 
reported that exercise resulted in a significant decrease in IL-6 and TNF-α by 50% and 
50% respectively whereas weight loss had no significant effect on IL-6 and TNF-α 
expression.  
In our study, we found a significant decrease in IL-6 and TNF-α. Our results 
agree with observation as observed by Lambert et al (84) in their study program that 
lasted 12 wk (84). Bruun et al (15) also reported a similar effect that a combination of 
exercise and caloric restriction led to a reduction in IL-6.  Gielen et al (53) also reported 
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that aerobic exercise training at about 70% VO2max for 20 min/d for 60 min/wk also 
significantly reduced IL-6 levels by 42%. Important we have shown that combining 
exercise and diet significantly reduced Il-6 and TNF-α with other inflammatory target 
genes. Mingrone et al (99) reported that a 23.6% decrease in body weight via gastric 
bypass resulted in an 82% decrease in TNF-α mRNA. All these studies confirm with our 
investigation that a decrease in body weight caused by exercise and diet led to a 
reduction in microRNAs and inflammatory cytokines. A reduction in body weight (fat 
mass) led a reduction in pro-inflammation level which led to an improvement in 
immune, hormonal and metabolism function. 
Our results suggest (IL-6 and TNF-α) in circulation may be involved in lipolysis 
(56, 136) and may promote physiological changes directly activate linked to NF-kB 
which has a direct effect on reducing inflammation (17, 18, 137). Each of these 
microRNA (21 and 146a) and mRNAs of IL-6, TNF-α, (PTEN, TRAF6)/PI3k/AKT/NF-
kB contributed to our inflammation response (90, 151-153, 161, 165, 168). The 
significant expression changes observed on inflammatory cytokines (IL-6 and TNF-α) 
(16, 93, 181) in our study program provides sufficient evidence to conclude that these 
observations are due to our exercise and diet-induced weight loss program and that 
exercise training protects against low-grade systemic inflammation link to obesity.  
Initially, we proposed two mechanisms that could be affected by exercise and 
diet-induced weight loss. The first pathway (pathway #1) microRNA-21, and 
PTEN/AKT/NF-kB and IL-6, TNF-α and our second pathway (pathway #2) microRNA-
146a and TRAF6/PI3K/AKT/NF-kB and IL-6 and TNF-α.  We proposed both pathways 
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could be affect by our exercise and diet-induced weight loss program. Our result data 
indicate the pathway (pathway #1) with microRNA-21 (p=0.03) and PTEN (p=0.005)  
/AKT(p=0.70) /NF-kB (p=0.40)  and IL-6 (p=0.00) and TNF-α (p=0.00) produced a 
significant change resulting in the reduction of inflammation than the pathway #2 with 
microRNA-146a (p=0.46) and TRAF6 (p=0.52) /PI3K (p=0.66) /AKT (p=0.70) /NF-kB 
(p=0.40) which produced some changes but not significant changes and shown on table 
14 above. Our findings on microRNA-21, mRNA PTEN, mRNA TNF-α and mRNA IL-
6 (pathway #1) led us to suggest that our exercise and diet intervention program 
promoted a reduction in inflammation and that microRNA-21 played a significant role in 
this biological process and greatly helped to be identified as a new intervention and 
therapeutic target in the obese population 
In general, our results indicate that exercise and diet-induced weight loss affects 
molecular changes in circulating microRNAs, significantly affects microRNA-21 and its 
target gene PTEN, mRNA TNF-α, and mRNA IL-6 levels suggesting an anti-
inflammatory response compared to a control group. Our result was in conformity with 
other research studies done on microRNA-21 and its target gen PTEN with significant 
changes with exercise on inflammation (8, 87, 88). These findings suggest that exercise 
and diet-induced weight loss is significantly relevant reducing inflammation caused by 
obesity. Our findings on microRNA-21, mRNA PTEN, mRNA TNF-α and mRNA IL-6 
(pathway #1) led us to suggest that our exercise and diet intervention program promoted 
a reduction in inflammation and that microRNA-21 played a significant role in this 
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biological process and greatly helped to be identified as a new intervention and 
therapeutic target in the obese population. 
The microRNA-21 has been shown to be involved in promoting inflammation; its 
overexpression enhances the inflammatory response by increasing the expression of 
other molecules related to inflammation and also reduces potent human anti-
inflammatory molecules (98). Also Olivieri et al (109) recently identified increasing 
circulating levels of microRNA-21 as a biomarker in inflammation. Keller et al (70) also 
showed that the microRNA-21 is robustly expressed in human adipose tissue and 
positively correlated to BMI. On the contrary our exercise and diet-induced weight loss 
program showed significantly reduction in microRNA-21 with its target gene PTEN and 
significant reductions in inflammatory cytokines of IL-6 and TNF-α, suggesting that 
microRNA-21 is linked to obesity and inflammation and could be a potential biomarker 
or therapeutic means in obesity treatment. These microRNAs modulate the NF-kB 
pathway related to cellular inflammation regulating several functions relevant to 
exercise. 
Moderate weight loss has been associated with improved health related quality of 
life (49, 141). Dekker et al (36) conducted a study to look at the effects of exercise and 
diet intervention on fasting plasma cytokine on subject who were required to participate 
in a 12 wk aerobic exercise program for 5 min/wk at 60% VO2max and followed a diet of 
55-60% carbohydrate, 15-20% proteins and 20-25% fat designed to maintain body 
weight after a weight loss program. They reported that plasma IL-6 was significantly 
reduced by 52% in type 2 diabetic followed by 32% and 17% in lean and obese subjects 
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respectively. This study also confirms with our exercise program that resulted in 
improved physical activity, body composition, markers of health and fitness and  
significant reduction in inflammation and genes related to inflammation (130, 132). 
However, more research is needed to understand microRNA regulation associated with 
inflammation in response to exercise and diet-induced weight loss. 
There are several limitations in conducting an exercise and diet-induced weight 
loss clinical trials that should be taken into account when interpreting the results of this 
investigation. First, the participants who volunteered to participate in our exercise and 
diet-induced weight loss trails were often more motivated to adhere to weight loss 
programs than the general population or control group. Secondly, the study participants 
are continually monitored and encouraged to meet program requirements. Thirdly, the 
results observed in our trial are limited to the population studied, sedentary and 
overweight/obese women, and may not be applicable to other populations. Other 
potential limitations to our investigation were that changes in mRNAs and microRNAs 
expression in blood samples during exercise still needs to be confirmed by protein 
expression and also the difficulty in isolating RNAs from blood samples. Although our 
finding on the effects of exercise and diet-induced weight loss on microRNAs and 
inflammatory cytokines are novel, they should be considered preliminary as this is the 
first study to investigate the effects of exercise and diet-induced weight loss on 
microRNA (21 and 146a) and inflammatory cytokine using blood samples collected 
from sedentary obese women compared to a control only group. Finally, results are 
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limited to the inherent difficulties in conducting a clinical trial of this nature, compliance 
to diet and/or exercise protocols, and the accuracy in data collection and analysis. 
Conclusion 
In our investigation, participants adhering to an exercise and diet intervention 
designed to promote fat loss experienced clinically significant weight loss, 
improvements in cardiovascular endurance, positive changes in some markers of health 
and fitness. We also observed a significant decrease in microRNA-21 that was positively 
and significantly correlated to changes in body weight, fat mass and body fat percent 
with significant reduction in circulatory levels of IL-6 and TNF-α. More specifically, we 
report that exercise and diet-induced weight loss significantly affects changes on 
microRNA-21 levels, some mRNAs related to inflammation (IL-6 and TNF-α) on our 
signaling pathway # 1. This could have important implications into the treatment and/or 
management of obesity treatment because our exercise and diet-induced weight loss 
program significant reduced markers of inflammation related to obesity in previously 
sedentary obese women. We therefore conclude that regular exercise training or chronic 
exercise adaptation reduces inflammation. Future research should evaluate the effect of 
chronic and acute exercise training on specific microRNAs related to inflammation in 
obese and insulin resistance individuals as well as the effects of different types of diet 
and exercise on microRNAs linked to inflammation, obesity, and weight loss.  
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APPENDIX A 
 
 
CONSENT FORM 
The effects of the Curves 90-Day Fitness Challenge on health outcomes in women 
 
Introduction 
The purpose of this form is to provide you information that may affect your decision as to whether or not 
to participate in this research study.  If you decide to participate in this study, this form will also be used to 
record your consent. 
 
You have been asked to participate in a research project comparing the Curves International fitness and 
weight loss program to other popular weight loss programs.  The purpose of this study is to determine the 
effects of the new Curves 90-Day Fitness Challenge on health outcomes in women.  You were selected to 
be a possible participant because you met all entrance criteria for this study.  This study is being 
sponsored/funded by Curves International.      
 
What will I be asked to do? 
If you agree to participate in this study, you will first be asked to sign an Informed Consent statement in 
compliance with the Human Subject’s Protection Program (HSPP) at Texas A&M University and the 
American College of Sports Medicine.  You will then be familiarized to the study requirements, food log 
recording and tests to be conducted during the study.  This session will take approximately one hour to 
complete.  Prior to reporting to the lab for baseline testing, you will record all food that you eat on dietary 
record forms for four days (including one weekend day).  You will not exercise for 48 hours nor eat for 12 
hours prior to reporting to the lab for baseline testing.  You will then undergo a battery of tests as 
described in Table 1.  You will fill out a Demographic Form, a Health History Form, A Radiation Safety 
Form, a Quality of Life Questionnaire, a Body Image Questionnaire and an eating Satisfaction 
Questionnaire.  You will also be required to report any adverse side effects that you may experience on a 
weekly basis.  .   
 
You will then continue with the tests as described in Table 1.  You will first be weighed and have your 
resting energy expenditure (REE) determined. This will involve lying down on an exam table and having a 
light blanket placed over you to keep you warm and placing ear plugs in your ears to reduce distractions.  
A see through plastic canopy will then be placed over your neck and head so that the air that you breathe 
can be measured for oxygen and carbon dioxide.  You should stay motionless without going to sleep for 
15-minutes so that your resting energy expenditure can be calculated. You will then donate up to 
approximately 30 milliliters (6 teaspoons) of venous blood from a vein in your arm. Blood samples will be 
obtained by standard/sterile procedures using a needle inserted into a vein in your arm and will later be 
analyzed. Personnel who will be taking your blood are experienced in phlebotomy (procedures to take 
blood samples) and are qualified to do so under guidelines established by the Texas Department of Health 
and Human Services.  This will take about 5-minutes.  You will then have your total body water 
determined using a bioelectrical impedance analyzer (BIA).  The BIA analysis will involve lying down on 
your back on a table and having two small electrodes placed on your right hand and your right foot.  The 
analyzer wires will be attached and a small and safe current (500 micro-amps at a frequency of 5- kHz) 
will pass through your body so that the amount of water can be measured. This analyzer is commercially 
available and has been used in the health care/fitness industry as a means to assess body composition and 
body water for over 20 years. The use of this device has been approved by the Food and Drug 
Administration (FDA) to assess total body water and the current to be used has been deemed safe.  Your 
body composition and bone density will then be determined by using a Discovery W dual energy x-ray 
absorptiometer (DEXA). This will involve lying down on your back on the DEXA exam table in a pair of 
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shorts or a gown for about 6 minutes.  A low dose of radiation will scan your entire body to determine the 
amount of fat weight, muscle weight, and bone weight. You will be exposed to an x-ray dose that is 
similar to the amount of natural background radiation a person would receive in one month while living in 
College Station.  After this test, you will have resting blood pressure determined using a blood pressure 
cuff and stethoscope and heart rate determined by taking your pulse.  You will then be prepared to perform 
a maximal treadmill test.  You will have your right and left shoulder, right and left part of your stomach, 
and several places around your upper chest and below your bra line rubbed with alcohol gauze.  Ten (10) 
electrocardiograph (ECG) electrodes will then be placed on your shoulders, chest, and stomach and you 
will be attached to an ECG to evaluate your heart.  You will then be positioned on the treadmill and a 
sterile mouthpiece will be placed in your mouth and a mouthpiece holder will be placed on your head.  A 
nose clip will be placed on your nose and that the air you breathe will be measured for oxygen and carbon 
dioxide content.  Once the equipment is attached, you will be given instructions to begin walking on the 
treadmill.  You will then perform an exercise test that involves increasing the speed and grade you are 
walking on the treadmill until you reach your maximal effort.  Heart rate, ECG tracings, blood pressure 
and your ratings of exertion will be monitored throughout the test.  Once you reach your maximum, you 
will undergo a slow walking and seated recovery period.  This test will take about 30 minutes to complete.  
You will then perform a one repetition maximum (1RM) and 80% of 1RM endurance repetition test on the 
bench press and hip/leg sled using standard procedures.  This will involve warming up and performing 
successive one repetition lifts on the bench press until you determine your 1 RM.  You will then rest for 5-
minutes and lift 80% of your 1 RM as many times as you can.  You will then rest for 10-minutes and 
follow the same procedure in determining your 1 RM and 80% of 1 RM on the hip/leg sled.  These tests 
will take about 20 minutes to complete.  The same battery of tests will be performed at the post-study 
assessment 16 weeks into the study protocol.  All the assessments minus the exercise tests will also be 
performed at 4, 6 10 and 12 weeks into the study protocol.  Each testing session will take between 1.5 and 
3 hours to complete.  In the event of an emergency during an exercise test proper emergency response 
protocols (calling 9-911 for serious injury or a medical emergency, calling Biosafety/EHS for cleanup 
assistance or spill team response, calling UPD for incidents in public areas, retrieving AED located in the 
lab, performing CPR or other First Aid techniques, etc.) will be followed by the Exercise & Sport 
Nutrition Laboratory (ESNL) Staff depending on the severity of the emergency.         
 
After baseline testing, you will be matched based on age, BMI, activity level and eating habits and 
randomized into one of six intervention groups as described in Table 2.  The Operating Systems (OS) 
Questionnaire (or Initial Assessment) will be used to help determine the group assignments.  This will 
include a high protein/low fat diet group (30% CHO, 45% PRO, 25% FAT, N=40), a high 
carbohydrate/low fat diet group (45% CHO, 30% PRO, 25% FAT, N=40), a Weight Watchers diet group 
(N=40), a Jenny Craig diet group (N=40), a Nutrisystem diet group (N=40) and a control group (N=40).  If 
you are randomized into one of the first two groups (N=80 total) you will diet for 7 days at 1,200 
kcals/day and then 1,500 kcals/day for the remaining 11 weeks of the study.  If you are in one of the first 
two groups you will meet weekly one on one with your weight loss coach for the duration of the study for 
weekly weigh-ins.  Each meeting will take place in the ESNL and will last approximately 15 minutes.  The 
coach will guide you through each phase of the program, assist with meal planning, assist with goal setting 
and provide accountability and encouragement in order to meet your fitness and nutrition goals.  If you are 
randomized into the third group (N=40) you will follow the Weight Watchers Momentum Program that is 
based on their four pillar approach (food, exercise, behavior and support).  Every food has a POINTS 
value, based on its calories, fat and fiber.  The Momentum program uses POINTS values to help keep 
track of what you eat.  A POINTS “budget” will be personalized for you at the weekly meetings.  You will 
be required to attend at least one meeting per week at the local Weight Watchers facility located at 4001 E. 
29
th
 Street, Suite 112 in the Carter Creek Center in Bryan, Texas.  Membership dues/passes to the Weight 
Watchers program/facility will be covered for you during the duration of the study.  If you are randomized 
into groups four or five (N=80 total), you will follow the dietary guidelines set forth by those respective 
plans.  The sixth group (N=40) will act as a control group.  If you are randomized into this group you will 
not follow a prescribed nutrition program but will continue with your normal daily habits.  Everyone, 
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regardless of group assignment, will keep a food record and food frequency log to monitor dietary 
compliance.     
 
If you are randomized to participate in the first two groups (N=80 total) you will participate in the Curves 
30-minute fitness program three times per week throughout the investigation.  The Curves program 
involves performing thirteen hydraulic resistance exercise machines that utilize bidirectional resistance 
that work all major muscle groups.  These are interspersed with floor-based calisthenics exercises 
designed to maintain an elevated heart rate.  Research has shown that exercise intensity averages 65% of 
maximal aerobic capacity and that participants generally perform 50 – 75% of 1 repetition maximum on 
the main exercise machines.  The new Curves equipment includes the attached force measurement and 
feedback system.  You will be instructed to push hard enough to generate a green light on the feedback 
panel for each repetition.  You will be instructed to wear heart rate monitors (HR) to access exercise 
intensity.  All exercise sessions will be held in the ESNL.  Research Assistants will monitor your exercise 
sessions and record your attendance. You will also be given a pedometer and will be recording the number 
of steps taken each day. On the days you do not use the Curves equipment, you will be encouraged to walk 
for 30-minutes at a brisk pace (60 – 80% of heart rate reserve). If you are randomized to participate in 
third group (N=40) you will start by focusing on the food plan and then incorporate the specifics of 
activity a week alter once you have had the chance to get conformable with the eating plan.  After a week 
of reducing sedentary behavior, the POINTS Activity System is introduced.  In a way that complements 
the POINTS values of food, a formula that calculates the POINTS values for activity is used.  The formula 
is based on body weight, the amount of time the activity is done, and the level of intensity.  This method 
enables you to do any exercise or activity that is enjoyable and fits within your lifestyle.  If you are 
assigned to groups four, five or six (N=120 total) you will not follow a prescribed exercise program but 
will continue your normal daily habits.  Everyone, regardless of group assignment, will be required to 
complete activity logs to monitor exercise frequency and intensity.       
 
Please do your best to:  1) follow the instructions outline by the investigators; 2) show up to all scheduled 
testing and train  ing sessions; and 3) follow the diet prescribed and do not take any other nutritional 
supplements or performance enhancing aids during this study (i.e., vitamins/minerals, creatine, HMB, 
androstenedione, DHEA, etc).  In addition, please do not take any non-medically prescribed medications 
and report any medication that is prescribed for you to take during this study.  If you take any other 
nutritional supplements or medications during the course of the study that may affect vitamin/mineral 
status, body composition, or strength you may be removed from the study.     
 
What are the risks involved in this study? 
The risks associated with this study are:  You will be exposed to a low level of radiation during the DEXA 
body composition tests, which is similar to the amount of natural background radiation you would receive 
in one month while living in College Station.  In addition, a very low level of electrical current will be 
passed through your body using a bioelectrical impedance analyzer (BIA). This analyzer is commercially 
available and has been used in the health care/fitness industry as a means to assess body composition and 
body water for over 20 years.  The use of the BIA and DEXA analyzers have been shown to be safe 
methods of assessing body composition and total body water and are approved by the FDA.  You will 
donate about 6 teaspoons (30 milliliters) of venous blood four (4) times during the study using standard 
phlebotomy procedures.   This procedure may cause a small amount of pain when the needle is inserted 
into the vein as well as some bleeding and bruising. You may also experience some dizziness, nausea, 
and/or faint if you are unaccustomed to having blood drawn.  The exercise tests that will be performed 
may cause symptoms of fatigue, shortness of breath, and/or muscular fatigue/discomfort.  The exercise 
tests may also cause short-term muscle soreness and moderate fatigue for several days following the tests.  
You may also experience muscle strains/pulls during the exercise testing and/or training program.  
However, exercise sessions will be conducted by trained personnel and monitored to ensure you follow 
appropriate exercise guidelines.  You will follow a prescribed dietary regimen involving consuming 1,200 
or 1,500 calories per day during various phases of the program.  In addition, one group will ingest a high 
percentage of calories in the form of protein.  Although the total amount of total protein is not excessive 
 94 
 
 
(100-220 grams/day or 1.1 - 2.3 grams/kg/day for a 95 kg female) it may be higher than you are 
accustomed to ingesting and may exceed recommended protein intake for active individuals (i.e., 1-2 
grams/kg/day).  As a result, you may experience weight loss or gain, feelings of hunger or fullness, and/or 
changes in appetite and/or mood during various phases of the dietary intervention.     
What are the possible benefits of this study? 
The possible benefit you may receive from participation in this study is increased physical fitness and 
improvements in body composition.  You may also gain insight about your health and fitness status from 
the assessments that will be performed.        
Do I have to participate? 
No.  Your participation is voluntary.  You may decide not to participate or to withdraw at any time without 
your current or future relations with Texas A&M University being affected.   
 
Will I be compensated? 
You will receive $125 (i.e., $25 for each familiarization and experimental session) upon completion of the 
study.  Disbursement will occur upon completion of all sessions and after all study related materials (food 
logs, training logs, etc.) are turned in.  Those who do not complete the study will be compensated on a pro-
rated basis depending on the total number of sessions completed (i.e. a participant who attends the 
familiarization session and completes only one experimental session is able to receive $50). 
 
Who will know about my participation in this research study? 
The records of this study will be kept private.  No identifiers linking you to this study will be included in 
any sort of report that might be published.  Research records will be stored securely and only Mr. 
Christopher Rasmussen and Dr. Richard Kreider will have access to the records.   
 
Whom do I contact with questions about the research?  
If you have questions regarding this study, you may contact Dr. Richard Kreider, 945-1333, 
rkreider@hlkn.tamu.edu or Mr. Christopher Rasmussen, 458-1741, crasmussen@hlkn.tamu.edu.  
 
Whom do I contact about my rights as a research participant?   
This research study has been reviewed by the Human Subjects’ Protection Program and/or the Institutional 
Review Board at Texas A&M University.  For research-related problems or questions regarding your 
rights as a research participant, you can contact these offices at (979)458-4067 or irb@tamu.edu. 
 
Signature   
Please be sure you have read the above information, asked questions and received answers to your 
satisfaction.  You will be given a copy of the consent form for your records.  By signing this document, 
you consent to participate in this study. 
 
Signature of Participant: ____________________________  Date: ______________ 
 
Printed Name: ________________________________________________________ 
 
Signature of Person Obtaining Consent: _________________Date: ______________ 
 
Printed Name: __________________________________________________________ 
 
                                                                                       
                                                                                                                   IRB-Protocol number 2010-0813 
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TEXAS A&M UNIVERSITY 
DIVISION OF RESEARCH AND GRADUATE STUDIES - OFFICE OF RESEARCH COMPLIANCE 
979.458.1467 
FAX 979.862.3176  
http://researchcompliance.tamu.edu  
 
Human Subjects Protection Program    Institutional Review Board 
 
 
DATE: 29-Apr-2011 
MEMORANDUM 
TO: KREIDER, RICHARD B. 
 
77843-4243 
FROM: Office of Research Compliance 
 
Institutional Review Board 
SUBJECT: Amendment 
 
Protocol 
Number: 
2010-0813 
Title: 
The effects of the Curves 90-Day Fitness Challenge 
on health outcomes in women 
Review 
Category: 
Full Board  
Approval 
Period: 
29-Apr-2011 To 08-Feb-2012  
 
Approval determination was based on the following Code of Federal Regulations: 
45 CFR 46 Subpart A. 
 
Provisions: 
Added 5 ml to blood draw for additional cytokine 
measures during scheduled blood draws. 
 
This research project has been approved for one (1) year. As principal investigator,you assume the 
following responsibilities 
1. Continuing Review: The protocol must be renewed each year in order to continue with the research 
project. A Continuing Review along with required documents must be submitted 30 days before the 
end of the approval period. Failure to do so may result in processing delays and/or non-renewal.  
2. Completion Report: Upon completion of the research project (including data analysis and final 
written papers), a Completion Report must be submitted to the IRB Office.  
3. Adverse Events: Adverse events must be reported to the IRB Office immediately.  
4. Amendments: Changes to the protocol must be requested by submitting an Amendment to the IRB 
Office for review. The Amendment must be approved by the IRB before being implemented.  
5. Informed Consent: Information must be presented to enable persons to voluntarily decide whether 
or not to participate in the research project.  
This electronic document provides notification of the review results by the Institutional Review Board. 
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APPENDIX B 
MEDICAL HISTORY QUESTIONNAIRE 
Texas A&M UNIVERSITY 
EXERCISE & SPORT NUTRITION LABORATORY 
 
Medical History Inventory 
 
Directions.  The purpose of this questionnaire is to enable the staff of the Exercise and Sport Sciences 
Laboratory to evaluate your health and fitness status.  Please answer the following questions to the best of 
your knowledge.  All information given is CONFIDENTIAL as described in the Informed Consent 
Statement. 
  
Name:____________________________________________ Age _____ 
Date of Birth_______________ 
 
Name and Address of Your Physician:_______________________________________ 
______________________________________________________________________ 
 
MEDICAL HISTORY 
 
Do you have or have you ever had any of the following conditions? (Please write the date when you had 
the condition in the blank). 
 
____ Heart murmur, clicks, other cardiac findings? ____  Asthma/breathing difficulty?  
____ Frequent extra, skipped, or rapid heartbeats?  ____ Bronchitis/Chest Cold? 
____ Chest Pain of Angina (with or without exertion)?    ____ Cancer, Melanoma, or Suspected Skin Lesions 
____ High cholesterol                  ____ Emphysema/lung disease 
____ Heart attack or any cardiac surgery? ____ Epilepsy/seizures? 
____ Leg cramps (during exercise)?  ___  Rheumatic fever? 
 ____ Chronic swollen ankles? ____ Scarlet fever? 
____ Varicose veins?                                                     ____ Ulcers? 
____ Frequent dizziness/fainting? ____ Pneumonia? 
____ Muscle or joint problems? ____ Anemias? 
____ High blood sugar/diabetes? ____ Liver or kidney disease 
____ Thyroid Disease?                                                  ____ Autoimmune disease? 
____ Low testosterone/hypogonadism? ____ Nerve disease? 
____ Glaucoma?                                                            ____ Psychological Disorders? 
 
 
Do you have or have you been diagnosed with any other medical condition not listed?  
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
Please provide any additional comments/explanations of your current or past medical history.  
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
  
 97 
 
 
Please list any recent surgery (i.e., type, dates etc.).  
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
List all prescribed/non-prescription medications and nutritional supplements you have taken in the last 3 
months.  
_____________________________________________________________________________________
_____________________________________________________________________________________  
 
What was the date of your last complete medical exam? 
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
Do you know of any medical problem that might make it dangerous or unwise for you to participate in this 
study? (including strength and maximal exercise tests)  ____ If yes, please 
expain._______________________________________________________________________________
_____________________________________________________________________________________ 
 
Recommendation for Participation (for ESNL use only):   
 
____ No exclusion criteria presented. Subject is cleared to participate in the study. 
____ Exclusion criteria is/are present. Subject is not cleared to participate in the study. 
 
Signed: ___________________________________ Date: ________________________ 
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APPENDIX C 
 
PERSONAL INFORMATION WORKSHEET 
Texas A&M University 
EXERCISE & SPORT NUTRITION LABORATORY 
 
Personal Information 
 
Name:  ____________________________________________________________________________
                                                                                                                                                  
Address:  ____________________________________________________________________________ 
                                                                                                                                                  
 
City:                                        State:                Zip Code               
 
Home Phone:     (      ) ____________________  Work Phone: (      ) ____________________                                
 
Beeper:  (      ) ____________________  Cell Phone: (      ) ____________________
  
Fax:  (      )                               E-mail address: _________________________ 
 
Birth date:            /            /              Age:  ________ Height:  _________Weight:  __________                 
Exercise History/Activity Questionnaire 
 
1. Describe your typical occupational activities. 
 
 
2. Describe your typical recreational activities 
 
 
3. Describe any exercise training that you routinely participate.  
 
 
4. How many days per week do you exercise/participate in these activities? 
 
 
5. How many hours per week do you train? 
 
 
6. How long (years/months) have you been consistently training? 
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APPENDIX D 
 
DATA COLLECTION FORM 
Texas A&M University: Exercise & Sport Nutrition Laboratory 
Trial: Effects of exercise and diet-induced weight loss on overweight women on characterization of 
serum/plasma microRNAs and cytokine gene transcription 
     
Demographics                    ESNL Staff Initials:  _____ 
 
Name: _____________________ Testing Session:  _____  Group:  _____   
Date:  _____        D.O.B.:  _____    Age:  _____ 
 
Resting Measures                   ESNL Staff Initials:  _____ 
 
Psychological Questionnaires/Informed Consent:  
 
HLKN Informed consent:    _____                   
Radiation consent:    _____                    
Activity Log:      _____          
Food Log:      _____    
Post-Study Questionnaire (T4 only):   _____ 
     
Physiological Parameters:    ESNL Staff Initials:  _____ 
 
Height:    _____ in.        
Weight:   _____ lb.        
REE #1:  _____        
Time:    _____am     
Last Meal:   _____am/pm     
Hrs Fasted: _____hr.      
Last Wkout: _____                                    DEXA #2:   _____ 
Lab (EBNL): _____  (3) SST Tubes/ (1) EDTA   ECG (Rest): _____ #1 or #2  
Time:   _____am    Max Test:     _____ #1 or #2 
Yr. /Menopause _______   Notes:   ___________________________________  
 
Exercise Measures:  Strength Testing:   ESNL Staff Initials:  ____ 
 
Leg Press:  Foot Position:  _____  Sled Position:  _____  
 
Preceding Weights/Reps:  _____x_____: _____x_____: _____x_____: _____x_____: _____x_____ 
1 RM:  _____     80% 1RM:  _____ 80% 1RM repetitions:  _____ 
 
Bench Press:  Hand Position:  _____  
 
Preceding Weights/Reps:  _____x_____: _____x_____: _____x_____: _____x_____: _____x_____ 
1 RM:  _____ 80% 1RM:  _____ 80% 1RM repetitions:  ____ 
 
